Podcasts about Hodgkin

Survivor: Africa winner Ethan Zohn joins Rev. Dr. Robin Swan for a powerful conversation about cancer, cannabis, resilience and finding purpose after a life-changing diagnosis. Ethan's life had already taken him from professional soccer to winning CBS's Survivor: Africa when, at age 35, he was diagnosed with a rare form of Hodgkin lymphoma. What followed was an intense medical journey involving chemotherapy, radiation, clinical trials and two stem cell transplants. In this episode, Ethan shares his personal experience with medical cannabis and how it became part of the way he managed some of the physical and emotional challenges surrounding cancer treatment and recovery, including nausea, pain, sleep difficulties and anxiety. Ethan and Robin also discuss the changing conversation around cannabis in professional sports, the importance of responsible education and advocacy, and why patients need honest information when making decisions about their health. The conversation goes far beyond cancer. Ethan explains how surviving a life-threatening illness reshaped his sense of purpose and strengthened his commitment to helping others. He discusses Grassroot Soccer, the nonprofit organization he co-founded that uses the power of soccer to improve the health and lives of young people around the world, as well as Kicking Back, his High Times series exploring the intersection of soccer, cannabis and community. In this episode: Ethan's journey from professional soccer to winning Survivor: Africa Being diagnosed with Hodgkin lymphoma at age 35 Chemotherapy, radiation, clinical trials and two stem cell transplants Ethan's personal experience using cannabis during cancer treatment and recovery Cannabis for nausea, pain, sleep and anxiety The emotional and psychological challenges of cancer survivorship How attitudes toward cannabis are changing in professional sports Cannabis education, responsible use and patient advocacy Turning personal crisis into purpose The story and mission behind Grassroot Soccer Ethan's Kicking Back series with High Times Soccer, cannabis and community Using lived experience to help others facing serious illness Learn more about Ethan Zohn Ethan Zohn:https://ethanzohn.com Grassroot Soccer:https://grassrootsoccer.org Cannabis Health Radio Visit:https://cannabishealthradio.com If this conversation could help someone you know, please share the episode. Subscribe to Cannabis Health Radio for more conversations with patients, advocates, researchers and others exploring cannabis, health and healing. Connect with Cannabis Health RadioVisit us at CannabisHealthRadio.comExplore products and resources from Swan ApothecaryFollow Cannabis Health Radio on Facebook and InstagramImportant DisclaimerThe views and opinions expressed by guests on Cannabis Health Radio (CHR) are their own and do not necessarily reflect those of CHR, its hosts, producers, affiliates, or sponsors. CHR is not responsible for statements or opinions expressed by its guests.Nothing presented in this episode constitutes medical advice, diagnosis, treatment, or a recommendation regarding what you should do. This content is provided for informational and entertainment purposes only. Always consult a qualified healthcare professional regarding your health, medical conditions, medications, or treatment decisions. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Apparently Gen X isn't going to enough concerts, so today we're solving the live music industry one folding chair and bottle of ibuprofen at a time.Episode 112 kicks off with a concert promoter asking what it would take to get Gen X back out to shows. The answers? Bring back physical tickets. Give us cleaner bathrooms. Stop making everything cost approximately one kidney. Fine bands for showing up late. And while we're making demands, how about concerts that start at 3 p.m. and wrap by 6 so everybody can be home, showered and questioning their life choices before the evening news?Welcome to the future of rock and roll: chairs.The crew gets into the bigger problem facing live music right now, from third-party ticket sellers and ridiculous resale prices to mid-level artists trying to survive while fans blow their entire entertainment budget on one or two giant shows. Rafe even pitches a concert subscription model where fans could pick shows from different tiers. Honestly, this comedy podcast may have accidentally stumbled into a legitimate business idea, which is deeply concerning.Then Crap on Celebrities arrives with enough music news to make everyone forget we were complaining about concerts five minutes earlier. Foo Fighters are stepping in to open for AC/DC in St. Louis, which leads to the very important question of how long the Foo Fighters actually get to play when they're technically the opener. There's also an update on Def Leppard guitarist Vivian Campbell and his continued battle with Hodgkin's lymphoma.From there, we enter one of our favorite genres of entertainment: successful musicians arguing with each other on the Internet.The Jack White and Charley Crockett drama continues after Twin Temple was removed from dates on Crockett's tour. Jack White defended the band, Crockett fired back, White responded with a bizarre musical troll, and suddenly everybody is keeping track of who released more albums. Rafe likes Crockett's music but would also like everyone involved to calm down and simply make songs again.Naturally, the crew decides celebrity boxing may be the only mature solution.Then Demon Hunter enters the chat. The Christian metal band is suing over the KPop Demon Hunters name, arguing that the massive Netflix property and its live-event expansion could create confusion with their long-established band. Moon actually has history with that music scene, which means for approximately four minutes this show accidentally becomes informative.Don't worry. We recover.There's also new testimony surrounding the Tupac Shakur murder case, a conversation about Sons of Anarchy stars reuniting for a bizarre meta-series, and a trailer for Whale Fall that sends everyone directly into claustrophobic nightmare territory. The movie involves a scuba diver getting swallowed by an 80-foot sperm whale and trying to escape before his oxygen runs out.Lern's reaction to this horrifying premise? Maybe watching it will help her prepare in case she ever gets swallowed by a whale.That's preparedness you simply won't get from other podcasts.We wrap things up with Jason Statham's latest movie accidentally appearing online early, John Stamos apparently deciding clothes are optional, and a Robert Plant birthday celebration that turns into Zeppelin, solo Plant, giant '80s hair and the invention of the word “plantiness.”So yes, this comedy podcast begins with concert economics and ends with Robert Plant's plantiness. That feels about right.It's another morning of St. Louis comedy, music news, entertainment gossip, pop culture commentary and sarcastic humor from Rizzuto and the gang — the comedy podcast where no topic survives contact with the studio.Follow The Rizzuto Show → linktr.ee/rizzshow for more from your favorite daily comedy show.Connect with The Rizzuto Show Comedy Podcast online → 1057thepoint.com/RizzShow.Hear The Rizz Show daily on the radio at 105.7 The Point | Hubbard Radio in St. Louis, MO.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The morning begins with Lern trying to figure out whether Hubbard Media has a sewage problem or whether she personally needs to reevaluate some life choices. Thankfully, the mystery quickly leads us to Florida, where somebody learns one of nature's most important rules the hard way: do not jump on a manatee. Especially when you haven't taken the time to determine whether said manatee is, you know… alive.Rizz remembers the beautiful bonding experience of having baby vomit deposited directly into his mouth. Moon recalls an athletic encounter with an impressive amount of dog poop. And then Rafe casually unlocks a repressed memory from his days working in surgery that probably should've stayed repressed. There's gangrene. There's a sterile operating room. There's vomiting. There's mint extract that arrives WAY too late. At one point, breakfast officially files for divorce.Eventually, Rizz attempts to drag this funny podcast out of the biological danger zone by choosing joy. Unfortunately, he's Rizz, so even his daughter thanking him for making dinner turns into an existential crisis involving garlic, dementia, stuffed animals, retirement in Florida, and an imaginary future son-in-law handling his estate. Normal father-daughter stuff.Then we actually get GOOD NEWS. St. Charles runner Emma Kessler thought she'd be tackling a half marathon without her boyfriend Jason, who repeatedly insisted running wasn't his thing. Turns out Jason had secretly trained for months so he could surprise her and run alongside her. It's sweet. It's supportive. Nobody gets covered in anything. Naturally, Rizz's immediate concern is that this man is making every other partner look terrible.Apparently Gen X isn't going to enough concerts, so today we're solving the live music industry one folding chair and bottle of ibuprofen at a time.A concert promoter asking what it would take to get Gen X back out to shows. The answers? Bring back physical tickets. Give us cleaner bathrooms. Stop making everything cost approximately one kidney. Fine bands for showing up late. And while we're making demands, how about concerts that start at 3 p.m. and wrap by 6 so everybody can be home, showered and questioning their life choices before the evening news?The crew gets into the bigger problem facing live music right now, from third-party ticket sellers and ridiculous resale prices to mid-level artists trying to survive while fans blow their entire entertainment budget on one or two giant shows. Foo Fighters are stepping in to open for AC/DC in St. Louis, which leads to the very important question of how long the Foo Fighters actually get to play when they're technically the opener. There's also an update on Def Leppard guitarist Vivian Campbell and his continued battle with Hodgkin's lymphoma.The Jack White and Charley Crockett drama continues after Twin Temple was removed from dates on Crockett's tour. Jack White defended the band, Crockett fired back, White responded with a bizarre musical troll, and suddenly everybody is keeping track of who released more albums. Rafe likes Crockett's music but would also like everyone involved to calm down and simply make songs again.Then Demon Hunter enters the chat. The Christian metal band is suing over the KPop Demon Hunters name, arguing that the massive Netflix property and its live-event expansion could create confusion with their long-established band. King Scott once saw the band demon hunter perform KPOP.The Missouri State Fair has given us many things over the years, and today we can add freeze-dried pickles capable of removing every drop of moisture from the human body to the list.Then we return to one of the most important educational developments of our generation: Fart Corner.The teacher whose classroom fart corner went viral has responded to all the attention and clarified her intentions. Apparently, kids today have significantly less shame about letting one rip in class, so she created a designated location where students can handle their business and return to society. Fart Corner is now also The Gas Station.Then it's time for King Scott to host Matchup With Moon, and whatever intellectual credibility remained in the studio immediately leaves through the emergency exit.Rizz and Moon battle through trivia involving the longest-running television game show, Walter Mondale, the PGA Hall of Fame, malware and the Rice Krispies mascots before King Scott drops the Millard Fillmore tiebreaker.Round two somehow gets worse. The guys tackle the undefeated Miami Dolphins, continents, Louis Armstrong, bowling terminology and the origin of Spam. “Spiced ham” should have been easy, but instead we get guesses including separated ham, spectacular meats, special mail and surplus meat.Then comes the Great Bowling Debate of 2023.Another episode of daily comedy from The Rizzuto Show.Follow The Rizzuto Show → linktr.ee/rizzshow for more from your favorite daily comedy show.Connect with The Rizzuto Show Comedy Podcast online → 1057thepoint.com/RizzShow.Hear The Rizz Show daily on the radio at 105.7 The Point | Hubbard Radio in St. Louis, MO.Boyfriend Secretly Trains For Two Months To Surprise Girlfriend and Run Alongside Her in Dreaded First Half-MarathonSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What if sound could help you heal?Sandy Duarte is an award-winning actress, author,  Stage IV non-Hodgkin lymphoma survivor, registered yoga instructor, and one of OncoDaily's 2026 Top 100 Most Influential Cancer Survivors. While undergoing aggressive chemotherapy, she turned to crystal singing bowls to calm her nervous system. Her practice has expanded into sound baths, women's retreats, and community healing, bringing the singing bowls to hospitals, corporate settings, and museum installations. In this interview, Sandy describes her personal experience using Peter Hess® therapy singing bowls, which are placed on the body specifically for Sound Massage. Sandy also talks about her book, Cancer Ramblings, a real-time reflection of her experience with cancer treatment.What is your experience with sound therapy? Leave a comment below!Visit Sandy's website: cancerramblings.comFollow Sandy on social media:https://www.instagram.com/sandy__duartehttps://x.com/sandyduartehttps://www.tiktok.com/@cancer.ramblingsFind her on IMDB. Buy her book on Amazon.Subscribe to her YouTube channel.Learn more about Peter Hess® Singing Bowls.Leave a message and let us know what you liked about the episode!Support the showBecome a member of The Cancer Pod Community! Support the podcast and gain access to exclusive content and more! Join today on Buy Me a Coffee or Patreon.Check out thecancerpod.com! Looking for more information? The website has blogs, merch, and all of the episodes listed by season and category. Shop the Bookshop! The shelves at Bookshop feature books by authors who have been on the show and other fav books.Buy The Cancer Pod merch! Whether it's a cozy hoody or a handy water bottle, we have something for everybody.Have a comment or suggestion? Email info (at) thecancerpod (dot) com Follow @TheCancerPod on social media:InstagramBlueskyFacebookLinkedInYouTube

Last week, startling headlines hit the news. Three commonly prescribed medicines, hydrochlorothiazide, used to treat high blood pressure, voriconazole, an antifungal medicine and tacrolimus, an immunosuppressant were classified as carcinogenic, or cancer causing, to humans. The classification was made by the International Agency for Research on Cancer or IARC, which is the World Health Organization's cancer research agency.According to the IARC, there is sufficient evidence that hydrochlorothiazide causes squamous cell carcinoma of the skin and cancer of the lip, as the drug makes the skin more sensitive to ultraviolet radiation. Voriconazole, also has been linked to the same cancers. In the case of Tacrolimus since it suppresses the immune system to prevent rejection of transplanted organs, the reduced immune surveillance may allow abnormal cells to proliferate and it is linked with non-Hodgkin lymphoma with limited evidence for other cancers as well.These drugs are prescribed to millions of people worldwide. So what happens now? Guest: Dr. Rajeev Jayadevan convener, research cell, Kerala State IMA and honorary senior consultant gastroenterologist, Sunrise Hospital, Kochi. Host: Zubeda Hamid Edited by Sharmada Venkatasubramanian Learn more about your ad choices. Visit megaphone.fm/adchoices

289: Teri McCall joins us to reflect on the life she built with her husband Jack, a farmer, before his death from non-Hodgkin's lymphoma. She talks about the early Monsanto litigation regarding Roundup (glyphosate) and why she chose to speak out publicly even when doing so felt frightening. Teri spoke at the People vs Poisons event in the spring of 26, just before the Supreme Court granted Bayer- Monsanto legal immunity against pesticide lawsuits. https://realorganicproject.org/teri-mccall-cancer-roundup-supreme-court The Real Organic Podcast is hosted by Dave Chapman and Linley Dixon, engineered by Brandon StCyr, and edited and produced by Jenny Prince. The Real Organic Project is a farmer-led movement working towards certifying 1,000 farms across the United States. Our add-on food label distinguishes soil-grown fruits and vegetables from hydroponically-raised produce, and pasture-raised meat, milk, and eggs from products harvested from animals in horrific confinement (CAFOs - confined animal feeding operations). To find a Real Organic farm near you, please visit: ⁠⁠⁠https://www.realorganicproject.org/directory⁠⁠⁠ We believe that the organic standards, with their focus on soil health, biodiversity, and animal welfare were written as they should be, but that the current lack of enforcement of those standards is jeopardizing the ability for small farms who adhere to the law to stay in business. The lack of enforcement is also jeopardizing the overall health of the customers who support the organic movement; customers who are not getting what they pay for at market but still paying a premium price. And the lack of enforcement is jeopardizing the very cycles (water, air, nutrients) that Earth relies upon to provide us all with a place to live, by pushing extractive, chemical agriculture to the forefront. To read our weekly newsletter and get firsthand news about what's happening with organic food, farming and policy, please subscribe here: ⁠⁠⁠https://www.realorganicproject.org/email/⁠

En avril 2022, la vie de Cynthia bascule. Après plusieurs signaux passés presque inaperçus, elle apprend qu'elle est atteinte d'un lymphome de Hodgkin de stade 4, avec une tumeur de près de 10 cm dans le médiastin.Commencent alors les traitements, les hospitalisations, la perte de contrôle et cette peur viscérale : celle que ses enfants grandissent sans leur maman.Cynthia affronte la maladie avec la conviction qu'elle va s'en sortir. Pourtant, lorsque les traitements s'arrêtent, un autre combat commence. Alors que son entourage la pense guérie, elle découvre la dépression, l'anxiété et le stress post-traumatique. Son corps a survécu, mais il continue de vivre en état d'alerte.Dans cet épisode, elle raconte avec une grande sincérité l'après-cancer, cette période invisible où il faut apprendre à vivre avec la peur de la récidive, les rendez-vous de contrôle, les souvenirs qui ressurgissent et un corps que l'on ne reconnaît plus. Elle évoque également son lipœdème, sa surdité, l'épuisement médical et la difficulté de continuer à tout porter en tant que femme et maman.Un témoignage bouleversant sur la maladie, la maternité, le traumatisme et la reconstruction. Parce que la rémission ne signifie pas toujours que tout est terminé, et qu'après avoir survécu, il faut parfois réapprendre à vivre.États Dames — Podcast santé & témoignagesUn podcast qui explore les parcours de santé des femmes à travers leurs émotions, leurs vécus et leurs réalités.

Joining the Project Purple Podcast from Manchester, Connecticut, pancreatic cancer survivor Michelle Richards and her husband and caregiver Brian share a powerful story of resilience, faith, and facing the unknown together with host Dino Verrelli. Having already navigated cancer many times within their family, including their son's battle with Hodgkin's lymphoma and multiple relatives affected, Michelle describes their diagnosis as “not our first rodeo,” yet one that brought entirely new challenges. After months of persistent symptoms like abdominal pain, fatigue, and discomfort, Michelle shares that she and Brian struggled to find answers, often feeling as though they were “out in the desert” searching for clarity. It wasn't until imaging in late 2024 revealed a tumor that their journey truly began, marked by conflicting diagnoses, emotional highs and lows, and the critical importance of trusting your instincts and advocating for your health. With support from family, including an oncologist niece, and second opinions from leading institutions, Michelle ultimately faced an aggressive pancreatic cancer diagnosis head-on. Throughout treatment, including chemotherapy, radiation, and a major surgery removing much of her pancreas and spleen, Michelle shares how she leaned into positivity, faith, and the belief that mindset plays a crucial role in healing. Brian offers an equally important perspective, reflecting on the caregiver experience and how life is forever changed after a diagnosis like this. From finding meaning in small signs, like rainbows, and placing deep faith in God's plan, to participating in and fundraising for Project Purple's Double Mile just as she finished radiation, Michelle's story is one of determination, community, and hope. Together, Michelle and Brian emphasize the importance of listening to your body, supporting both survivors and caregivers, and choosing strength in the face of uncertainty. Michelle welcomes connection through her Instagram and Facebook pages: https://www.instagram.com/seashell1023 https://www.facebook.com/michelle.s.richards.5/ Subscribe to the Project Purple Podcast for more stories from the pancreatic cancer community. To learn more or donate to Project Purple's mission of a world without pancreatic cancer, visit www.projectpurple.org.

A heart-moving episode about the unimaginable courage it takes to live after loss. When Pamela Shainhouse's daughter, Alli, died at 26 after seven years of fighting Hodgkin lymphoma, Pamela felt that the person she had been died with her. In the silence that followed came a life-altering question: Who would she become now?   In this deeply personal conversation, Pamela shares how Alli taught her to live fully, to refuse the limits others place on us, and to understand the profound difference between moving on and moving forward.   Pamela also speaks candidly about growing up with a disability, enduring bullying, becoming a caregiver, and navigating a grief that reshaped every part of her life. She reflects on the 16-year journey of writing her memoir, Daughter Dies, Mother Lives On—a testament to the daughter she lost and the woman she fought to become.   This is a powerful conversation about a mother's enduring love, the struggle to rebuild an identity after unimaginable loss, and the possibility of finding purpose, not beyond grief, but within the love that remains.   To learn more about what Pamela does: https://www.theshainhousegroup.com

On episode #112 of the Infectious Disease Puscast, Daniel reviews the infectious disease literature for the weeks of 7/20 – 8/3/26. Host: Daniel Griffin and Sara Dong Subscribe (free): Apple Podcasts, RSS, email Become a patron of Puscast! Links for this episode Viral The genomic identity of early smallpox in South America (Science) Telltale DNA: First direct evidence found that the Spanishbrought smallpox to the Inca (CIDRAP) Phase 3 Trial of Weekly Oral Islatravir–Lenacapavir for HIV-1 Treatment (NEJM) Early Transcriptional Signature in Chikungunya PredictsChronic Arthralgia and Reveals Deficient Antiviral Response (JID) Bacterial IDSA 2026 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections (IDSA) Doxycycline in the treatment of outpatient mild community-acquired pneumonia: a propensity-matched retrospective cohort study (CMI: Clinical Microbiology and Infection) Detection of pathogens in the gut microbiome priorto bloodstream infection in children with acute myeloid leukemia or mature B-cell non-Hodgkin lymphoma (Journal of Pediatric Infectious Diseases Society) Fungal The Last of US Season 2 (YouTube) Active Surveillance for Invasive Mold Disease — Four Hospitals, Atlanta, Georgia, 2020–2024 (CDC: MMWR) Does the Evidence Support High-Dose Liposomal Amphotericin B in the Treatment of Mucormycosis? (JID) Miscellaneous Evaluation of the impact of a novel surgical handwashing method on reformation of microbial flora on surgeons' hands (Infection Control & Hospital Epidemiology) Association Between First MMR Vaccination Before Age 2 Years and Childhood Autism in a U.S. EHR Cohort of 2.5 Million Children (Journal of Pediatric Infectious Diseases Society) Music is by Ronald Jenkees Information on this podcast should not be considered as medical advice.

Hodgkin lymphoma is a relatively rare disease, with approximately 82 409 incident cases reported globally in 2022, and 8720 cases reported in the US in 2025. Author Alison Moskowitz, MD, of Memorial Sloan Kettering Cancer Center joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss current evidence about the diagnosis and management of Hodgkin lymphoma in adults. Related Content: Classic Hodgkin Lymphoma

Un figlio cambia sempre il bilancio di una famiglia. Cambiano le spese, le priorità, le paure, il modo in cui si immagina il futuro. Anche quando quel figlio non nasce dal tuo corpo, ma arriva attraverso un'adozione.Rossella ha 37 anni, vive a Piacenza, lavora nel sociale e insieme al marito ha scelto l'adozione nazionale. Una decisione pensata a lungo, rimandata anche per ragioni economiche, poi diventata urgente dopo il Covid e dopo la perdita di una persona cara.La procedura di adozione nazionale in Italia è gratuita: non si pagano agenzie, intermediari o percorsi privati. Ma questo non significa che il denaro resti fuori dalla storia. Ci sono i permessi presi al lavoro, gli spostamenti, i colloqui, i documenti, il tempo dell'attesa. E poi c'è tutto quello che arriva dopo: una casa da riorganizzare, nuove spese, assegno unico da gestire, un piccolo fondo da immaginare per il futuro.Nel caso di Rossella, la genitorialità porta con sé anche un bisogno ancora più forte di protezione. Durante l'iter di adozione ha scoperto di avere un linfoma non Hodgkin, superato dopo il primo ciclo di terapia. Una malattia che l'ha resa più consapevole di quanto sia importante tutelare la propria famiglia anche davanti all'ipotesi di una propria assenza, temporanea o definitiva.Oggi Rossella e suo marito vogliono capire come proteggere il futuro economico del loro bambino, come usare bene le risorse che arrivano per lui, come costruire un fondo nel tempo e come integrare una pensione che, per chi lavora nel sociale, rischia di poggiare su basi contributive fragili.Perché pianificare l'arrivo di un figlio non significa solo comprare quello che serve adesso. Significa costruire un margine per gli imprevisti, pensare alla protezione della famiglia, iniziare presto a mettere da parte risorse per il futuro e dare al proprio amore anche una forma economica.Ad aiutare Rossella a orientarsi tra fondo di emergenza, piano di accumulo, polizza vita, salute e previdenza integrativa c'è Silvia Seresi, consulente di Alleanza Assicurazioni dell'Agenzia di Teramo.Questa è Money Clinic, il podcast di Rame in collaborazione con Alleanza Assicurazioni: storie vere di grandi cambiamenti, e le domande economiche che possono renderli più sostenibili.

Bethany Smith is a fighter.  Almost immediately after surviving Hodgkin lymphoma, she was diagnosed with metastatic follicular thyroid cancer.  In addition to having her thyroid removed, she also underwent total hip replacement.  All this while raising three small children.  Treatment of her lymphoma included a chemotherapy regimen of adriamycin, bleomycin, vinblastine and dacarbzin.  Her treatment for thyroid cancer featured radioactive iodine.  Bethany credits oxygen therapy for helping her to become free of thyroid cancer and these maintains her health with levothyroxine.   Bethany cannot tell you exactly when she first detected in the vicinity of her thyroid.  It had been there for years when her mother visited, saw the lump and insisted she seek medical attention.  This led to a series of scans and the discovery of a second lump near her clavicle.  A biopsy of the lump on her collarbone resulted in a diagnosis of Hodgkin lymphoma in the Autumn of 2022, while the biopsy of the lump on her thyroid came back as "indeterminant."  Bethany's care team said it would turn its attention to the thyroid lump after addressing her lymphoma diagnosis.   She was placed on a six-month regimen of ABVD chemotherapy, which included adriamycin, bleomycin, vinblastine and dacarbazine.  Bethany suffered many of the usual side effects tied to chemo, including fatigue, nausea and hair loss.  The latter forced her to cut her hair short and then the purchase of a half dozen wigs of different colors.    Bethany attained survivorship from Hodgkin lymphoma, but halfway through her chemo, she underwent a PET scan, which showed two lesions, one on her C5 vertebrae and one on hip.  She underwent a biopsy on the lump on her thyroid in the Spring of 2023, which not only indicated follicular thyroid cancer, but that it had metastasized to the bones in her vertebrae and right hip.    Bethany had to undergo a thyroidectomy and because was eating away at her right hip, it, too, had to be removed.   In September 2023, she began a three-dose regimen of radioactive iodine, which forced her to be kept in isolation.  She was given another CT scan that revealed that cancer was in twelve places in her bones.   Bethany said the pain of her hip replacement exceeded that of three times giving birth without painkillers.  She says she is able to walk just fine these days, walking that includes her love for hiking, and her lack of a thyroid is successfully addressed with levothyroxine, which replaces the hormones lost when her thyroid was removed.   Bethany Smith has experienced the physical toll of her two cancer journeys, but then and now, she deals with everything that has come her way with her natural and boundless sense of optimism.   Additional Resources:   Bethany's app: https://www.stillcancercompanion.com   Bethany's YouTube channel: Bethany Smith Cancer          

Episode Title: A Community of Hope: Sera's Journey to a Life-Saving Kidney Transplant Episode Description:  In this inspiring episode of This Thing Called Life, host Andi Johnson sits down with Hali and Sera Davis to share their family's remarkable journey from uncertainty to hope. They reflect on the power of resilience, the unwavering support of their community, and how one young stranger's decision to become a living donor gave Sera the opportunity to live the childhood every parent dreams of. It's a heartfelt reminder that one act of generosity can transform an entire family's future. Episode Highlights Host Andi Johnson welcomes Hali Davis and her daughter Sera, who share the remarkable story of Sera's journey from critical illness to a thriving life after kidney transplantation. Hali reflects on Sera's difficult birth, explaining how a placental abruption caused significant brain, liver, and kidney damage shortly before delivery. While Sera's liver healed on its own, her kidneys were permanently affected, requiring dialysis throughout her early childhood as her family waited for a transplant. Sera, now 12 years old, shares that she has very few memories of dialysis and instead enjoys talking about the life she's able to live today—from spending time with friends to looking forward to moving to a farm and finally getting the pet pig she's always wanted. Hali explains that she made a conscious decision not to let kidney disease define her daughter. Instead, she encouraged Sera to focus on being a child by dancing, attending sleepovers, participating in activities she loved, and celebrating life's everyday moments. As transplant became the next step, family members and close friends volunteered to be tested as potential living donors. One promising donor was ultimately unable to proceed after being diagnosed with non-Hodgkin's lymphoma during the evaluation process—a reminder that donor screening can also uncover previously unknown health conditions. After exhausting many personal connections, Hali turned to social media, sharing Sera's story in hopes that someone would step forward. The post quickly spread throughout the community, being shared more than a thousand times and eventually reaching employees at Hali's husband's workplace. Among those who saw the post was Alex, a 21-year-old who had watched his own mother endure two kidney transplants and felt called to spare another family from a similar journey. Alex volunteered to be tested, was found to be a compatible living donor, and ultimately gave Sera the life-saving kidney transplant she desperately needed. Hali and Sera reflect on the emotions surrounding transplant day and the overwhelming gratitude they continue to feel for Alex's extraordinary act of generosity. Sera shares one of her favorite post-transplant memories: throwing the ceremonial first pitch at a University of Kentucky softball game—a milestone celebrating both her recovery and her new beginning. Hali expresses heartfelt appreciation for Dr. Ancheta, the pediatric nephrology team, and the many healthcare professionals who cared for Sera throughout every stage of her journey. Looking back, Hali encourages other families facing serious medical challenges to trust their healthcare team, advocate for their children, ask questions, and never lose hope. Sera offers simple but powerful advice to other children experiencing difficult health journeys: stay hopeful, believe in yourself, and remember that brighter days are possible. Key Takeaways 1. A Child's Diagnosis Doesn't Have to Define Their Life Hali intentionally focused on giving Sera a joyful childhood despite years of medical treatment, reminding families that children are more than their diagnosis. 2. Community Has the Power to Change Lives A single Facebook post—and one stranger's willingness to help—led to the living kidney donation that transformed Sera's future, demonstrating the incredible impact of compassion and community. 3. Hope Often Arrives in Unexpected Ways From medical breakthroughs to unexpected donors, Sera's story is a powerful reminder that perseverance, faith, and generosity can open doors when families least expect it. Tweetable Quotes “I didn't want her to feel like all she is is kidney disease or getting a transplant. We took our medicine. Really focused on keeping our body healthy, good foods and stuff. And then we danced. We slam. We did all the things that Sarah enjoys, and really kept her going on that positive track.” Hali Davis “I took that next step: family, friends, and because there are so many people that rally behind Sera, so family friends got tested as well, and we had a match.” Hali Davis “I shared it on Facebook, and then it got shared over 1000s of times. So it really kind of made it throughout the community and even out to other states. And my husband's company also shared it with their employees.” Hali Davis “He (Alex, living donor) said his reasoning for wanting to do this is because he watched his mother go through two transplants, through two kidney transplants, and he didn't want a little girl to suffer like that.” Hali Davis Resources: Donatelifeky.org https://getoffthelist.org/ https://www.networkforhope.org/ https://www.networkforhope.org/about-us/ https://www.networkforhope.org/stories-of-hope/ https://www.facebook.com/NetworkForHopeOPO https://www.youtube.com/@NetworkforHope. https://aopo.org/ RegisterMe.org/NetworkforHope

Faith doesn't erase fear, but it does shape how you walk through it. In this episode, Pastor Caleb and Willow revisit her journey with Hodgkin's lymphoma, and how daily prayer, simple health habits, and a faithful community helped them keep grounded in faith. The post 11 Taking Mountains | A Christian Faith Podcast | “I Didn’t Let Cancer Become Who I Was” appeared first on Christian Faith.

In March 2025, Keri Darling fell out of bed and hit her head.  A trip to the doctor revealed a large mass on her pancreas.  After a series of scans, Keri received a phone call at work from a nurse who told her she had cancer; not cancer of the pancreas, but a type of blood cancer, Stage IV follicular non-Hodgkin lymphoma.  She was put on a regimen of chemotherapy, bendamustine, followed by immunotherapy, rituximab.  Keri has achieved survivorship, but each day deals with severe fatigue, which she believes is tied to her chemo regimen.  She still goes in for bimonthly injections of rituximab and says he expects to always be dealing with some level of fatigue.  Nonetheless, she finds the time and energy to help others as a cancer coach.   Two years prior to March 2025, Keri was constantly feeling fatigued.  This was annoying, but she had no idea what was behind her feeling so tired so often.  Then in the middle of the night on a Friday, she got out of bed, fell and hit her head.  She and her husband went to the emergency room.  After some scans, doctors detected a large mass on Keri's pancreas.  She and her husband were terrified that she had pancreatic cancer.  A nurse referred her to an oncologist and a gastroenterologist.    Keri said this wasn't a good time for her to deal with a potential cancer diagnosis.  She was just about to start a new job and the insurance from her previous job was going to lapse in a week.  A nurse urged Keri to get insurance through COBRA, which she did.  Nonetheless, she still had to juggle her health and a new job.    She went to a GI doctor who performed a biopsy.  Keri was at work when she received a call from a nurse telling her she had been diagnosed not with pancreatic cancer, but with Stage IV follicular non-Hodgkin lymphoma.  In terms of treatment, she was given three options and chose a mix of chemotherapy and immunotherapy.  The chemotherapy was bendamustine and the immunotherapy was rituximab.   Keri said she had been prescribed medication to combat the ensuing nausea, but that the toughest part of her chemo regimen was the constant fatigue.  She was also plagued with cognitive issues that resulted in post-its all over her home and a lot of attention paid to the calendar on her phone.   Keri Darling says if she thinks to the time before she started feeling constant fatigue in 2023, and thought of her health as 100 percent, now her health is at around 40 percent.  She says every day she feels fatigued.  It is merely a question of how fatigued she will feel, but she approaches each day as a chance for her health to improve over the previous day.   Additional Resources:   Keri's coaching website:   https://www.nexttogether.co (NOT .com)  

Listen without ads at 8$ a month or up on patreon: www.patreon.com/dopeypodcast SUMMARY This week on Dopey Greatest Hits, Dave officially declares July to be Allman Brothers Month and revisits one of his favorite interviews—with Duane Betts, guitarist, songwriter and son of the legendary Dickey Betts. Before the interview, Dave talks about his lifelong love of “Blue Sky,” reflects on a difficult Patreon Zoom and reminds himself of one of recovery's hardest lessons: restraint of pen and tongue. Papa Smurf contributes an incredible story about selling mushrooms in an Allman Brothers parking lot, getting grabbed by undercover cops and escaping after an oblivious hippie accidentally distracts them. A listener named Jeff also shares a disastrous Phish adventure involving craft beer, moonshine, cocaine, getting lost outside the venue while “Maze” played in the distance, wandering through a locked campground and receiving a possession charge that ultimately introduced him to AA. Then Dave sits down with Duane Betts for an intimate and wide-ranging conversation about growing up inside the Allman Brothers family, touring with his father, living at Cher's Malibu home, learning guitar on the road and finding his own musical identity. Duane opens up about Hodgkin lymphoma, discovering Dilaudid after surgery, the Malibu party scene, Molly, cocaine, crack, black tar heroin and a gram-a-day opiate habit. He recalls smoking heroin-and-cocaine speedballs, flipping a car after scoring drugs, waking up beside a friend who had overdosed and nearly dying after a massive cocaine hit. He also describes arrests, drug court, treatment, Suboxone, relapse, touring with Dawes and eventually finding lasting recovery. Now more than seven years sober, Duane talks about meeting his wife in Jackson Hole, staying grounded through music, hiking, yoga and connection, and continuing the Allman Brothers legacy through his solo work, Palmetto Motel and the Allman Betts Family Revival. It is a story about rock-and-roll history, inherited addiction, devastating loss, recovery and finding a life filled with music, gratitude and purpose. Allman Brothers month continues!   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

It's Tuesday, July 14th, A.D. 2026. This is The Worldview in 5 Minutes heard on 140 radio stations and at www.TheWorldview.com.  I'm Adam McManus. (Adam@TheWorldview.com) By Kevin Swanson, Timothy Reed and Adam McManus Fulani Muslim militia most deadly force against Christians The Observatory for Religious Freedom in Africa has issued a study on terror-related violence on the Dark Continent. The group revealed that the Fulani Muslim militia is by far the most deadly force in the persecution of Christians worldwide. They kill Christians at a rate 4.4 times that of other Muslims. Thus far, they have killed 79,323 people in six years — amounting to 36 people a day. They kill at 3 times the rate of Boko Haram. That's twenty times the number of people that have been killed in the US-Iran war this year.  Senegal, Africa: Marriage is between one man and one woman The National Assembly of the West African country of Senegal has defined marriage as a union between one man and one woman. Homosexuality is still legal in 21 out of 54 African countries. So far, homosexual faux marriage has been incorporated in one nation -- South Africa. U.S.-Iran war is back on America's war with Iran is back on, and the Middle East is in flames.   The U.S. military bombed dozens of military targets yesterday. The Saudis also bombed the Yemen airport. The Houthi-controlled Yemeni government is an ally with Iran in the present war. The Center for Strategic and International Studies reports a depletion of one-third to one-half of American Patriot, Tomahawk, and Terminal High Altitude Areas Defense missiles. At current rates, the replenishment will take four years. This does not include the use of missiles during the period of May through July.  Trump Meme coin tanked; Bitcoin down by 50% The Trump Meme coin has tanked — costing investors $3.8 billion. The president received $636 million from the venture, according to a recent financial disclosure.  However, Bitcoin has also lost half its value since the Trump election in November 2024. Total losses are running about $2.2 trillion for investors. Gold capitalization has increased about 3% since November 2025. 122,000 American layoffs The website Layoffs.fyi records 122,000 layoffs this year. That's the highest rate in four years.  Amazon is leading the pack for corporate layoffs with a total of 30,000 layoffs over the last nine months. America produces more oil than Saudi Arabia and Russia America is now, by far, the largest oil producer in the world — now producing 42% more than Saudi Arabia, and 37% more than Russia. Back in 2008, the United States produced about half of what Saudi Arabia and Russia produced. That has changed dramatically in the last 17 years.  GOP Senator Mitch McConnell rejects rumors he's braindead Republican Senator Mitch McConnell of Kentucky broke the silence and intrigue surrounding his lengthy hospital stay. Rumors had swirled that the senator was braindead or under cardiac arrest after he was transferred to the hospital. The senator has clarified that he had suffered a fall, but he did not break bones or suffer a concussion. Senator Lindsey Graham met his maker Longtime Republican Senator Lindsey Graham of South Carolina went to meet his Maker on Saturday night. According to the D.C. office of the Chief Medical Examiner, Graham died of a ruptured aorta brought on by chronic heart disease. Graham, age 71, was never married and never had children. SC Gov appointed Lindsey Graham's sister to serve remainder of term South Carolina Republican Governor Henry McMaster announced Monday that he has appointed the late Senator's sister, Darline Graham Nordone, to serve the remainder of his term. When Lindsey Graham was 20, his mother died of Hodgkin's lymphoma at age 50, and his father died 15 months later of a heart attack at age 68. Because his sister, then 13 years old, was left orphaned, the service allowed Graham to attend the University of South Carolina in Columbia so he could remain near home as his sister's legal guardian. Here's a portion of Governor McMaster's press conference. McMASTER: “Today, under the law, it's my duty and honor to name someone to serve in the place this extraordinary man for the remainder of his term. “Lindsey took care of his little sister in years long departed. It's my honor to ask his little sister, Darlene Graham, to finish his work for him now. “And by the way, Darlene, I don't know if I told you, but after we spoke on the phone in the wee hours of Sunday morning, and you agreed to serve, through tears. Earlier, I had wondered what you would say, and I was humbled by your quickness to see the duty that you had to serve. “I called the president afterwards, and he thought it was a great idea, and I'm sure that everyone here does as well.” Obamacare premiums going higher Obamacare premiums are jacking up another 14% for next year.   That follows a 20% increase last year. The Peterson-KFF organization notes that the program lost three million members so far this year — now at a total of 19.2 million enrollments.  The average family of four pays $24,000 into Obamacare for this year, and $27,000 next year.  That compares to Samaritan Ministries Christian medical sharing that runs about $8,000 per year.  Hospitals treated COVID-shot rejectors as “plagued rats” Psalm 146:3 instructs us: “to not put your trust in princes, nor in a son of man, in whom there is no help.” Recent Centers for Disease Control numbers indicate that 80% of Americans got at least one COVID shot. U.S. death rates, based on 2019 numbers, rose 17% in 2020 during the COVID crisis. After the vaccine came out in early 2021, the death rate increased again by 23% over 2019 levels. Then, the death rate increased by 16% in 2022. Death rates did not reduce to 2019 levels until 2024. Last year's death rate actually registered 4% less than 2019. Former trauma surgeon Dr. James Miller told podcast host Alix Mayer that those who did not take the Covid shot, after its rollout, were treated differently in hospitals, and in an inhumane manner, like “plagued rats.” Listen. MILLER: “Absolutely, the vaccinated and unvaccinated were treated differently. They started just denying basic health services to unvaccinated people, which spurned not giving diabetes medicine [and] you can't go see your family doctor. "Now, you could still get emergency care in the ER, but 100% you were treated differently. You were treated as a dirty, plagued rat. And this was common in social media. But it was no different in the hospital. The medical community is no different.” Next, Dr. Miller spoke of The Overton Window referring to the moment when an argument becomes politically acceptable to the mainstream population. In this case, it is more acceptable now, in 2026, for Americans to express their distrust of the medical establishment about how it handled the COVID shot rollout and how it mistreated the unvaccinated 20% of the population. The term, The Overton Window, is named after the American policy analyst Joseph Overton. Listen. MILLER: “I think part of why this is such a good time to talk about this is I think The Overton Window has shifted on the discussion. I think all people have realized the medical care system did not meet their expectations during COVID. “I think most people thought, before COVID, when you go to the doctor, they're going to help you out a bit, and you're going to get better, and they're going to wish you well. I think most people thought when I'm really sick, I'm going to go to the hospital and they're gonna help me out a lot and do their best and get me well. “After COVID, most people realized their doctors were there for themselves. Their doctors were more than happy to give them a toxic substance that would hurt them, like the COVID injection. And I think most people came to see that the hospitals were really killing fields.” 28 Georgia inmates got baptized after Bible studies The Grady County, Georgia Sheriff's department issued an official announcement over the weekend: 28 inmates got baptized! They had been faithfully attending Bible studies throughout the week, and confessed their faith in Christ.   The announcement said, “Together, we gathered in prayer, lifted our voices in worship, and celebrated these life-changing decisions. Moments like these serve as a reminder that hope, grace, and redemption are possible for everyone.” Back in March, another 14 inmates were baptized at a Franklin County jailhouse in Florida, according to Channel 7 News. PASTOR: “I'm going to baptize you in the name of the Father and of the Son and of the Holy Spirit. And I'm baptizing you in the power of that cross I'm talking about today. All right, ready?” These inmates also attended Bible studies each week and heard sermons from local pastors. Inmate Ethan Vonier became a Christian behind bars. VONIER: “I found Christ in jail. I feel like the good Lord put me here. We're all doing better each day.” And inmate Robert Hill was grateful for a fresh start and a Biblical destiny. HILL: “It's a new beginning. Everybody in here probably wants a new beginning. You know, he gives it to you. You know what I mean? Gives you a fresh start.  Jeremiah 29:11 -- He has a plan for me. I know it. I want it. I'm going to get it.” Psalm 107:10-14 tells the story: “Those who sat in darkness and in the shadow of death, bound in affliction and irons—because they rebelled against the words of God, and despised the counsel of the Most High. Therefore, He brought down their heart with labor. They fell down, and there was none to help. Then, they cried out to the Lord in their trouble and He saved them out of their distresses. He brought them out of darkness and the shadow of death, and broke their chains in pieces.” Worldview listeners weigh in from Virginia and Texas Joseph Holt, age 20, at Liberty University in Lynchburg, Virginia, wrote me to say, “Thanks for faithfully presenting the news every morning. I like your podcast because it's short and concise. I can get a briefing on the news while I'm brushing my teeth in the morning before work or school starts. You present the facts from a Biblical worldview and do not shrink from condemning evil. Thanks for keeping this up so long. Here's to another great year!” And Richard Powell in Lonetta, Texas wrote, “I appreciate how much time you guys save me by putting the newscast together so I don't have to filter through so much.  I also appreciate that it's concise and that you come from a Biblical perspective.  I typically read it as part of my morning routine.” 8 Worldview listeners gave $2,760 And finally, on Monday by 8:00pm Central, 8 Worldview listeners had stepped up to the plate and invested their treasure to fund the six-member team behind The Worldview for another year Our thanks to Sarina in Barnwell, Alberta, Canada who gave $25, Janna in Midvale, Idaho who gave $75, and Susan in Timnath, Colorado who gave $100. We were touched by the generosity of Bianca in Manzini, Eswatini, Africa who pledged $15/month for 12 months for a total gift of $180. Since their money is worth one-sixteenth what ours is worth, it's like Bianca donated $2,965. Imagine that! And we're grateful to God for Dwayne and Anita in Moriarty, New Mexico who gave $200, Frances in Beacon, New York who pledged $40/month for 12 months for a gift of $480, Stuart in Zillah, Washington who gave $500, and Tim in Blooming Grove, Texas who pledged $100/month for a total gift of $1,200. Those 8 gifts add up to $2,760. Ready for our new grand total? Drum roll please. (drum roll sound effect) $23,803 (sound effect of people cheering) That means we need to raise $32,762 to hit our $56,565 goal by this Friday, July 17th.   We need to find 8 Worldview listeners, just like Tim did, who will pledge $100/month for 12 months, or give a one-time gift of $1,200, 19 folks who will pledge $50/month or give a one-time gift of $600 and 38 listeners who will pledge $25/month or give a one-time gift of $300. Go to TheWorldview.com, click on Give, select the dollar amount, and make sure to click on the “recurring” button if that's your wish.  If Bianca from Eswatini, Africa can give the equivalent of $2,965, what could you give? Go to TheWorldview.com and click on Give. Close And that's The Worldview on this Tuesday, July 14th, in the year of our Lord 2026. Subscribe for free by Spotify, Amazon Music, or by iTunes or email to our unique Christian newscast at www.TheWorldview.com.  Plus, you can get the Generations app through Google Play or The App Store. I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.

When Dr. Timothy Blain opened his direct primary care practice in the middle of COVID, he finally felt like a “real doctor” again — after two decades of employed medicine, five-year burnout cycles, and the constant ache of knowing he could help patients but never had the time.In this honest and moving episode, Dr. Blain shares his full journey: graduating in 2000 as hospitals bought up practices, surviving non-Hodgkin lymphoma at 38, then weathering COVID pneumonia, a heart attack, and adult-onset Still's disease — all while continuing to care for his patients. He opens up about how DPC helped save his marriage, why empathy is the first thing burnout takes from physicians, and what it truly means to be the patient when you're also the doctor.Dr. Concepcion and Dr. Blain dig into:•The 5-year burnout curve, and why “just take a half day” never works•Building patient loyalty so deep that almost no one left, even through his hospitalizations•Practical steps for leaving employed medicine for DPC (including the prepay discount that funded his startup)•Why DPC doctors may be best positioned to use AI in medicine•Supplements, home visits, ultrasound, and staying curious as a physician•How and why he chose to close his practice — the taxes, timing, and grief involved•Redefining “failure” and finding peace in a one-year sabbaticalWhether you're burned out and dreaming of a way out, a few years into your own DPC, or simply wondering what a fulfilling end to a medical career can look like, this conversation is a breath of fresh air.“Failure is in the eye of the beholder.” — Dr. Timothy Blain—

Broadcast from KSQD, Santa Cruz on 7-09-2026: Researchers refined a technique to reverse skin cell aging by about 30 years while preserving cellular identity. Exposing adult fibroblasts to Yamanaka factors—stopping before full reversion to pluripotent stem cells,reset the epigenetic clock and gene expression patterns to resemble much younger cells. The rejuvenated fibroblasts produced significantly more collagen, migrated faster to close artificial wounds, and showed reversal of gene expression patterns associated with Alzheimer's and cataracts. Since long-term epidemiologic data doesn't yet exist, Dr. Dawn follows up on last week's vaping question by exploring cancer mechanisms. Vaping aerosols impair DNA repair fidelity while triggering IL-6, IL-8, and TNF-alpha secretion. Nicotine-derived nitrosamines, reactive carbonyls (formaldehyde, acetaldehyde, acrolein) are generated when propylene glycol and vegetable glycerin are heated. Upregulated cytochrome P450 enzymes convert precarcinogens like benzopyrene into carcinogens. Mice exposed for 54 weeks developed lung adenocarcinomas in 22% and precancerous bladder hyperplasia in 57%, with markers matching those show predict lung cancer years before diagnosis. The Mexican Biobank—which includes over 40,000 samples from all 31 Mexican states revealed dramatic regional variation in drug-metabolism genes driven by Indigenous ancestry. In Chiapas, nearly 40% of the population carries two copies of a CYP2D6 variant reducing fentanyl metabolism, versus just 10% in Sinaloa. The SLCO1B1 variant hindering statin metabolism is found in over 15% of Yucatán residents., where 8 million Mexicans take statins. Dr. Dawn discusses both the promise and potential dark side of population genetic testing, including UK plans to genotype all children at birth for inborn errors of metabolism. Dr. Dawn briefly revisits the recent Indian study showing conch-shell blowing reduces sleep apnea by 34%, comparing it to earlier didgeridoo research, both of which strengthen airway muscles through forced-blowing exercises. A caller from Capitola recovering from non-Hodgkin's lymphoma near the L5 nerve asks about Japanese Kampo medicine formulas (Goshajinkigan, Yokukansan) for post-treatment nerve pain. Dr. Dawn suggests the pain likely originates from scar tissue tethering the nerve, and recommends consulting the Oriental Medicine Doctor program at Five Branches in Santa Cruz where faculty can advise on herbal formulas that trace back thousands of years through cultural exchange between China and Japan. Dr. Dawn explains Lp(a):lipoprotein(a), a small protein string attached to LDL particles that promotes clumping and clotting, is a genetically-determined coronary artery disease and stroke risk factor invisible to standard lipid panels. Levels of 250 particles double coronary risk and 350 particles triple it. Less than 75 is normal. Two new pharmaceutical strategies are in development to reduce Lp(a) : antisense oligonucleotides (single-stranded RNA that recruits RNase H to cleave target mRNA) and small interfering RNA (double-stranded RNA that triggers destruction of matching mRNA). Pelacarsen, a monthly injection in Phase 3 trials, reduces Lp(a) by 80%. These gene-silencing platforms open therapeutic possibilities for previously undruggable orphan diseases. Vitamin K2 is produced in the gut microbiome. MK-4 is most common in humans. Dr. Dawn recommends MK7 for stabilizing coronary calcium plaques and directing calcium into bone. A study of hepatitis B and C patients found MK4 to be protective in hepatocellular carcinoma. HCC developed in 2 of 21 MK-4-treated patients versus 9 of 19 controls, with a risk ratio of 0.2. MK-4 activates protein kinase A in vitro, inhibits HCC invasiveness, and restores apoptosis signaling that cancer cells normally block. Dr. Dawn recommends a couple milligrams of MK-4 daily for anyone with cirrhosis or prior hepatitis B or C infection.

Alex Herrera, MD, discusses the FDA approval of nivolumab plus AVD for untreated classical Hodgkin lymphoma.

After earning her first-class degree in chemistry from Oxford, Dorothy embarked on an impressive career in the new field of X-ray crystallography. She would ultimately earn many, many accolades for her work. Research: "Dorothy Crowfoot Hodgkin." Encyclopedia of World Biography Online, Gale, 1998. Gale In Context: Opposing Viewpoints, Biophysical Society. “Profiles in Biophysics: Dorothy Hodgkin.” 2016. https://www.biophysics.org/profiles/dorothy-hodgkin Boon, Rachel. “Curator Rachel Boon celebrates the work of Dorothy Hodgkin.” Science Museum. 12/10/2014. https://blog.sciencemuseum.org.uk/celebrating-dorothy-hodgkin-britains-first-female-winner-of-a-nobel-science-prize/ Bragg, Sir William. “Concerning The Nature Of Things.” London. Bell & Sons. 1932. https://archive.org/details/in.ernet.dli.2015.222386/ Bud, Robert. "Discoverers and developers of penicillin (act. 1928–1950)." Oxford Dictionary of National Biography. May 21, 2009. Oxford University Press. Date of access 22 Jun. 2026, https://www.oxforddnb.com/view/10.1093/ref:odnb/9780198614128.001.0001/odnb-9780198614128-e-97279 Dodson, Guy. “Dorothy Mary Crowfoot Hodgkin, O.M. 12 May 1910--29 July 1994.” Biographical Memoirs of Fellows of the Royal Society , Dec., 2002, Vol. 48 (Dec., 2002). Via JSTOR. https://www.jstor.org/stable/3650256 DOROTHY CROWFOOT HODGKIN. NobelPrize.org. Nobel Prize Outreach 2026. Wed. 24 Jun 2026. https://www.nobelprize.org/stories/women-who-changed-science/dorothy-hodgkin/ Ferry, Georgina. "Dorothy Hodgkin". Encyclopedia Britannica, 8 May. 2026, https://www.britannica.com/biography/Dorothy-Hodgkin. Accessed 24 June 2026. Ferry, Georgina. "Hodgkin, Dorothy Mary Crowfoot (1910–1994), chemist and crystallographer." Oxford Dictionary of National Biography. May 21, 2009. Oxford University Press. Date of access 22 Jun. 2026, https://www.oxforddnb.com/view/10.1093/ref:odnb/9780198614128.001.0001/odnb-9780198614128-e-55028 Ferry, Georgina. “Dorothy Hodgkin: A Life.” Bloomsbury. 1998, 2014. Ferry, Georgina. “Dorothy Hodgkin: on proteins and patterns.” The Lancet, 384, 1496-1497. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)61912-7/fulltext Ferry, Georgina. “The making of an exceptional scientist.” Nature. Vol. 464. April 29, 2010. Gamble, Jessa. “When Hodgkin met Thatcher.” Nature. Vol. 514. October 16, 2014. Hodgkin, Dorothy Crowfoot. “The X-ray analysis of complicated molecules.” Nobel Lecture, December 11, 1964. https://www.nobelprize.org/uploads/2018/06/hodgkin-lecture-1.pdf Hodgkin, Dorothy. “The Pugwash Movement.” India International Centre Quarterly. Vol. 13, No. 2. June 1986. Via JSTOR. https://www.jstor.org/stable/23001474 Howard, Judith A.K. “Dorothy Hodgkin and her contributions to biochemistry.” Nature Reviews. Vol. 4. November 2003. gale.com/apps/doc/K1631003072/GPS?u=mlin_n_melpub&sid=bookmark-GPS&xid=8d7c4045. Accessed 23 June 2026. Pearce, JMS. “Dorothy Crowfoot Hodgkin OM, FRS (1910-1994).” Hektoen International. https://hekint.org/2020/11/04/dorothy-crowfoot-hodgkin-om-frs-1910-1994/ Perutz, Max. “Dorothy Crowfoot ” The Independent. Via The Crystallographic Community. https://www.iucr.org/people/crystallographers/dorothy-crowfoot-hodgkin-by-m.f.-perutz Pietzsch, Jochim. “Perspectives: Enhancing X-ray vision.” Nobel Prize. https://www.nobelprize.org/prizes/chemistry/1964/perspectives/ Ramaseshan, S. “Dorothy Hodgkin and the Indian Connection.” Notes and Records of the Royal Society of London , Jan., 1996. http://www.jstor.com/stable/531845 Root-Bernstein, Robert. “Dorothy Crowfoot Hodgkin: Structure as Art.” Leonardo , 2007, Vol. 40, No. 3 (2007). Via JSTOR. https://www.jstor.org/stable/20206415 Science History Institute Museum and Library. “Dorothy Crowfoot Hodgkin.” https://www.sciencehistory.org/education/scientific-biographies/dorothy-crowfoot-hodgkin/ The Royal Society. “Dorothy Hodgkin FRS.” https://royalsociety.org/about-us/who-we-are/diversity-inclusion/case-studies/scientists-with-disabilities/dorothy-hodgkin/ “Science for peace Building cultures of cooperation and non-violence through scientific collaboration.” 2025. Via JSTOR. https://www.jstor.org/stable/resrep73183.6 University of Oxford History of Science Museum. “Modelling the Structure of Penicillin.” https://www.mhs.ox.ac.uk/backfromthedead/exhibition/the-structure-of-penicillin/index.html Vijayan, M. “An outstanding scientist and great humanist: An obituary of Dorothy Crowfoot Hodgkin.” Current Science, 10 August 1994, Vol. 67, No. 3 (10 August 1994). Via JSTOR. https://www.jstor.org/stable/24095820 Wallace, Rob. “Dorothy Crowfoot Hodgkin: Captured by Crystals.” National World War II 3/16/2022. https://www.nationalww2museum.org/war/articles/dorothy-hodgkin-penicillin-insulin See omnystudio.com/listener for privacy information.

This Day in Legal History: Vermont Bans SlaveryOn July 8, 1777, delegates meeting in Windsor adopted the Constitution of the Vermont Republic—and in doing so, Vermont became the first place in North America to write the prohibition of slavery into its founding law. At a moment when the newly declared United States tolerated and protected human bondage, a small, unrecognized republic on the frontier put a very different principle on paper.The relevant language was striking for its era. The Vermont constitution declared that all people are born equally free and independent, and it provided that no adult could be held as a servant, slave, or apprentice against their will—specifically, no man over twenty-one and no woman over eighteen. It was not a complete abolition; the age limits meant the document did not immediately free everyone, and enforcement in practice was uneven and incomplete for years afterward. But as a matter of constitutional text, it was the first time on this continent that a government's foundational law declared slavery inconsistent with the very idea of being born free.The context matters. In 1777, Vermont was not yet a state—it wouldn't join the Union until 1791—and it existed in a kind of legal limbo, claimed by both New York and New Hampshire and recognized by neither. That outsider status may have given its drafters room to be bolder than their contemporaries. While the framers of the national government were negotiating the compromises that would embed slavery in American law for another four generations—the three-fifths clause, the fugitive slave clause, the twenty-year protection of the slave trade—Vermont's drafters wrote the opposite conviction into their first article.The significance of July 8, 1777 is partly symbolic and partly practical. Symbolically, it established that abolition was not some later invention imposed on a reluctant founding generation, but a principle that existed at the founding itself, chosen by people who could see the contradiction between declaring all men free and holding some in bondage. Practically, Vermont's provision became an early data point in the long argument that would run through the Northwest Ordinance, the gradual emancipation statutes of the northern states, the abolitionist movement, the Civil War, and finally the Thirteenth Amendment. It's a reminder that constitutional law is not just handed down from the most powerful actors—that sometimes the boldest legal principles come from the margins, from a place that wasn't even sure it counted as a state, writing down what it believed the law ought to be.A former Milwaukee County judge, Hannah Dugan, has been sentenced in federal court after being convicted of obstructing an immigration arrest outside her courtroom—a case that became a flashpoint in the fight over the Trump administration's use of courthouses to stage immigration enforcement. Dugan, who is 67 and was an elected circuit court judge, was found guilty of obstructing a federal proceeding, though a jury acquitted her of a lesser concealment charge.Federal immigration agents came to Dugan's courthouse to arrest Eduardo Flores-Ruiz, a Mexican man who was scheduled to appear before her on misdemeanor assault charges. Prosecutors said Dugan directed him out through a non-public “jury door” in an effort to help him avoid the agents waiting in the public hallway. It didn't work—Flores-Ruiz walked through a public hallway with his attorney anyway, and agents arrested him outside after a brief foot chase. But the government charged Dugan criminally for what she did inside the courthouse, and a federal jury convicted her in December.Think about the competing principles colliding here. On one side is the idea that no one, not even a judge, gets to physically obstruct federal law enforcement carrying out its duties. On the other is a real institutional worry that animated a lot of the coverage: if immigration agents stake out courthouses, people with pending cases—victims, witnesses, defendants—may stop showing up at all, which grinds the ordinary work of the state courts to a halt. Dugan's defenders framed her actions as protecting the functioning of her courtroom; prosecutors framed them as obstruction of a federal operation. The jury sided with the government on the core charge.At sentencing, the two sides were far apart. Federal prosecutors declined to recommend a specific term but argued the guidelines called for fifteen to twenty-one months in prison. Dugan's lawyers disputed that calculation and asked U.S. District Judge Lynn Adelman for time served—no prison at all. The significance of the case goes well beyond one judge. It's a marker of how aggressively the administration is willing to pursue anyone perceived to interfere with immigration enforcement, up to and including a sitting judge, and it sends a message to state and local officials everywhere about the personal legal risk of getting between federal agents and their targets.Ex-Wisconsin judge to be sentenced for obstructing immigration arrest | ReutersBayer is moving to bring an end to the sprawling federal litigation over its Roundup weedkiller, following a significant win at the Supreme Court. Late last month, the Court ruled 7-2 in Bayer's favor, and the company is now trying to convert that decision into the dismissal of the failure-to-warn claims that have driven nearly a decade of lawsuits.Thousands of plaintiffs have sued Bayer alleging that Roundup, and specifically its active ingredient glyphosate, caused their non-Hodgkin lymphoma, and that the company violated state law by failing to warn them of that cancer risk. Bayer's winning argument was about federal preemption—the principle that when federal and state law conflict, federal law wins. Bayer argued that because the Environmental Protection Agency has concluded glyphosate poses no cancer risk and requires no cancer warning on the label, plaintiffs can't use state failure-to-warn law to demand a warning the federal regulator affirmatively says isn't needed. The Supreme Court agreed, overturning a $1.25 million Missouri verdict in the process.Consider why this is such a powerful tool for Bayer. A failure-to-warn claim says, in essence, “you should have told me this was dangerous.” But if the federal agency in charge has studied the product and decided no warning is warranted, then a state jury ordering the company to warn anyway would effectively be overriding the federal regulator. Preemption resolves that conflict in favor of the federal standard. The practical effect is that the single most common theory in the Roundup litigation—failure to warn—is now largely off the table in the cases this ruling reaches.The significance is real but, importantly, not total. This should let Bayer dismiss current warning-based claims and block future ones, which is exactly why the company is now pressing courts to wind down the federal litigation, and it's pairing that push with a proposed $7.25 billion class-action settlement to sweep in remaining Roundup users. But the decision doesn't make every claim disappear. Plaintiffs may still pursue theories that don't depend on a failure to warn—like defective design—and the settlement obligations remain. So this is a milestone in Bayer's long campaign to contain its liability, not the final word. It's also a notable example of how federal regulatory findings can become a shield against state tort law, a doctrine with implications well beyond weedkiller.Bayer seeks end to federal Roundup litigation after Supreme Court win | ReutersFederal judges are sounding skeptical of a California law that bans employers from forcing workers to attend so-called “captive audience” meetings—mandatory gatherings where a company shares its views on political or religious matters, most often its opposition to unionizing. The law has already been blocked by a district court, and the signs from the bench suggest that skepticism may carry through on appeal.Here's what a captive audience meeting is and why it's contested. When a union organizing drive is underway, employers have long held mandatory meetings where attendance is required and workers listen to management make the case against unionizing. Unions call these coercive; employers call them protected speech. California's SB 399 tried to ban compelling attendance at meetings covering “political matters,” a category defined broadly enough to include unionization. Judge Daniel Calabretta of the Eastern District of California blocked the law, and his reasoning is the crux of the whole fight.He gave two independent grounds, and it's worth separating them. The first is federal preemption—the same principle at work in the Bayer story. Calabretta found that the National Labor Relations Act, which governs labor relations nationwide, occupies this field and preempts California's attempt to regulate it under the Machinists and Garmon preemption doctrines. The second ground is the First Amendment: he held that the law was a content-based restriction on employer speech, singling out “political” and “religious” topics, and that it couldn't survive strict scrutiny—the most demanding test in constitutional law, which almost nothing passes. In his view, banning all speech on those topics in mandatory meetings swept far too broadly.The significance here is that this is a collision between the labor movement's priorities and employers' free-speech claims, and right now the free-speech and preemption arguments are winning in court. A number of states have passed captive-audience bans, so how the Ninth Circuit ultimately rules—California and Attorney General Rob Bonta are expected to appeal—will shape whether this entire category of worker-protection law survives. It's a reminder that even popular labor legislation has to run a gauntlet of federal preemption and the First Amendment, and that employer speech, including anti-union speech, gets substantial constitutional protection.US judges leery of California ban on workplace captive-audience meetings | Reuters This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.minimumcomp.com/subscribe

Dorothy Hodgkin's career in X-ray crystallography impacted a lot of science in the 20th century. Part one of her story covers her early life and formative experiences that led her to her field of research. Research: "Dorothy Crowfoot Hodgkin." Encyclopedia of World Biography Online, Gale, 1998. Gale In Context: Opposing Viewpoints, Biophysical Society. “Profiles in Biophysics: Dorothy Hodgkin.” 2016. https://www.biophysics.org/profiles/dorothy-hodgkin Boon, Rachel. “Curator Rachel Boon celebrates the work of Dorothy Hodgkin.” Science Museum. 12/10/2014. https://blog.sciencemuseum.org.uk/celebrating-dorothy-hodgkin-britains-first-female-winner-of-a-nobel-science-prize/ Bragg, Sir William. “Concerning The Nature Of Things.” London. Bell & Sons. 1932. https://archive.org/details/in.ernet.dli.2015.222386/ Bud, Robert. "Discoverers and developers of penicillin (act. 1928–1950)." Oxford Dictionary of National Biography. May 21, 2009. Oxford University Press. Date of access 22 Jun. 2026, https://www.oxforddnb.com/view/10.1093/ref:odnb/9780198614128.001.0001/odnb-9780198614128-e-97279 Dodson, Guy. “Dorothy Mary Crowfoot Hodgkin, O.M. 12 May 1910--29 July 1994.” Biographical Memoirs of Fellows of the Royal Society , Dec., 2002, Vol. 48 (Dec., 2002). Via JSTOR. https://www.jstor.org/stable/3650256 DOROTHY CROWFOOT HODGKIN. NobelPrize.org. Nobel Prize Outreach 2026. Wed. 24 Jun 2026. https://www.nobelprize.org/stories/women-who-changed-science/dorothy-hodgkin/ Ferry, Georgina. "Dorothy Hodgkin". Encyclopedia Britannica, 8 May. 2026, https://www.britannica.com/biography/Dorothy-Hodgkin. Accessed 24 June 2026. Ferry, Georgina. "Hodgkin, Dorothy Mary Crowfoot (1910–1994), chemist and crystallographer." Oxford Dictionary of National Biography. May 21, 2009. Oxford University Press. Date of access 22 Jun. 2026, https://www.oxforddnb.com/view/10.1093/ref:odnb/9780198614128.001.0001/odnb-9780198614128-e-55028 Ferry, Georgina. “Dorothy Hodgkin: A Life.” Bloomsbury. 1998, 2014. Ferry, Georgina. “Dorothy Hodgkin: on proteins and patterns.” The Lancet, 384, 1496-1497. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)61912-7/fulltext Ferry, Georgina. “The making of an exceptional scientist.” Nature. Vol. 464. April 29, 2010. Gamble, Jessa. “When Hodgkin met Thatcher.” Nature. Vol. 514. October 16, 2014. Hodgkin, Dorothy Crowfoot. “The X-ray analysis of complicated molecules.” Nobel Lecture, December 11, 1964. https://www.nobelprize.org/uploads/2018/06/hodgkin-lecture-1.pdf Hodgkin, Dorothy. “The Pugwash Movement.” India International Centre Quarterly. Vol. 13, No. 2. June 1986. Via JSTOR. https://www.jstor.org/stable/23001474 Howard, Judith A.K. “Dorothy Hodgkin and her contributions to biochemistry.” Nature Reviews. Vol. 4. November 2003. gale.com/apps/doc/K1631003072/GPS?u=mlin_n_melpub&sid=bookmark-GPS&xid=8d7c4045. Accessed 23 June 2026. Pearce, JMS. “Dorothy Crowfoot Hodgkin OM, FRS (1910-1994).” Hektoen International. https://hekint.org/2020/11/04/dorothy-crowfoot-hodgkin-om-frs-1910-1994/ Perutz, Max. “Dorothy Crowfoot ” The Independent. Via The Crystallographic Community. https://www.iucr.org/people/crystallographers/dorothy-crowfoot-hodgkin-by-m.f.-perutz Pietzsch, Jochim. “Perspectives: Enhancing X-ray vision.” Nobel Prize. https://www.nobelprize.org/prizes/chemistry/1964/perspectives/ Ramaseshan, S. “Dorothy Hodgkin and the Indian Connection.” Notes and Records of the Royal Society of London , Jan., 1996. http://www.jstor.com/stable/531845 Root-Bernstein, Robert. “Dorothy Crowfoot Hodgkin: Structure as Art.” Leonardo , 2007, Vol. 40, No. 3 (2007). Via JSTOR. https://www.jstor.org/stable/20206415 Science History Institute Museum and Library. “Dorothy Crowfoot Hodgkin.” https://www.sciencehistory.org/education/scientific-biographies/dorothy-crowfoot-hodgkin/ The Royal Society. “Dorothy Hodgkin FRS.” https://royalsociety.org/about-us/who-we-are/diversity-inclusion/case-studies/scientists-with-disabilities/dorothy-hodgkin/ “Science for peace Building cultures of cooperation and non-violence through scientific collaboration.” 2025. Via JSTOR. https://www.jstor.org/stable/resrep73183.6 University of Oxford History of Science Museum. “Modelling the Structure of Penicillin.” https://www.mhs.ox.ac.uk/backfromthedead/exhibition/the-structure-of-penicillin/index.html Vijayan, M. “An outstanding scientist and great humanist: An obituary of Dorothy Crowfoot Hodgkin.” Current Science, 10 August 1994, Vol. 67, No. 3 (10 August 1994). Via JSTOR. https://www.jstor.org/stable/24095820 Wallace, Rob. “Dorothy Crowfoot Hodgkin: Captured by Crystals.” National World War II 3/16/2022. https://www.nationalww2museum.org/war/articles/dorothy-hodgkin-penicillin-insulin See omnystudio.com/listener for privacy information.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of significant advancements and strategic shifts reshaping the industry landscape. To begin, the U.S. Food and Drug Administration has taken a noteworthy step by selecting key industry players, including Eli Lilly, Regeneron, Fujifilm, and Kriya Therapeutics, for its PreCheck pilot program. This initiative is designed to enhance U.S. drug manufacturing capabilities, emphasizing the importance of robust domestic production. By reducing dependency on international supply chains, the program aims to expedite the delivery of critical therapies, highlighting a strategic move towards self-reliance in pharmaceutical manufacturing. In oncology news, Beone's Brukinsa (zanubrutinib), a small molecule BTK inhibitor, has demonstrated a remarkable 43% reduction in risk of progression for patients with first-line mantle cell lymphoma in its Phase 3 trial. This breakthrough offers a promising chemotherapy-free option for non-Hodgkin lymphoma treatment, marking significant progress in targeted cancer therapies that could improve patient outcomes in previously underserved areas. Meanwhile, Boulevard Bio and Metis TechBio have sealed a substantial licensing agreement valued at $1.6 billion for MTS-128, a trispecific T-cell engager aimed at autoimmune diseases. This collaboration reflects a broader industry trend towards leveraging advanced AI and machine learning technologies to enhance the development of precision medicine and personalized therapies. Such partnerships indicate a shift towards more innovative approaches to tackling complex disease mechanisms and illustrate burgeoning interest in multispecific biologics within immunotherapy domains—offering new avenues for targeting multiple disease pathways simultaneously. On the regulatory front, Sanofi is advancing efforts to expand the U.S. label for Nexviazyme (avalglucosidase alfa) following successful Phase 3 trials for infantile-onset Pompe disease. As an enzyme replacement therapy targeting GAA enzyme deficiency, Nexviazyme could address a critical gap in treatment options for this debilitating genetic disorder, underlining the importance of regulatory pathways in facilitating access to life-saving therapies. Financially, Beeline Medicines has garnered $126.3 million in Series A extension funding to propel its autoimmune programs originally sourced from Bristol Myers Squibb. Similarly, SmartBax has raised €6.3 million to advance its lead antibiotic program targeting multi-drug resistant infections. These investments underscore an unwavering focus on addressing unmet medical needs through innovative therapeutic solutions. Regulatory challenges persist as well; Unicycive Therapeutics faced FDA rejection due to third-party manufacturing deficiencies surrounding oxylanthanum carbonate. This setback emphasizes the critical importance of maintaining rigorous quality standards throughout drug production processes to secure regulatory approvals and ensure patient safety. Globally, China has achieved a milestone with the approval of the world's first CAR-T therapy for solid tumors—a significant leap forward given the historical challenges of applying CAR-T technology beyond hematological malignancies. This approval could transform cancer treatment paradigms globally and prompt similar regulatory advancements in other regions. In other developments, Abbvie and Genmab's combination therapy involving Epkinly has shown promise in diffuse large B-cell lymphoma (DLBCL) trials following prior challenges with monotherapy approaches. This success story highlights the potential of combination therapies in enhancing outcomes for patients battling complex cancers like DLBCL. From a corporate perspective, Klick Health's acquisition of Oxford Pharmagenesis marks its third purchase in 18 months, expanding its global footprint and scientific capabilities—a testament to ongoing consolidation trends aimed at augmenting expertise and strategic growth within the sector. These developments collectively paint a picture of an industry dynamically evolving amidst scientific breakthroughs and regulatory recalibrations. As companies navigate this transformative landscape, their ability to adapt and innovate remains paramount for sustaining growth and addressing global healthcare challenges effectively. Stakeholders must remain agile to seize opportunities while mitigating inherent risks in this high-stakes environment that increasingly prioritizes patient-centric innovations.Support the show

This week we welcome the boy Foster Moreau back to the pod, and it's safe to say Foster has had one of the craziest offseasons of all NFL Players. The boys immediately get some hot takes about some actor as well as get into some conspiracy theories. Foster shares some stories of his time at LSU about different bars he used to go to and just the town itself. The boys then get into Foster’s crazy offseason. He was diagnosed with Hodgkin's Lymphoma in March while on a visit to the Saints. He shares the story of how he found out from his physical and the exact type of cancer he was diagnosed with. Foster gets into what it was like telling his family and friends and how difficult it was. The boys then lighten the mood as they get into how he has officially been signed to the New Orleans Saints and is reunited with Derek Carr. The boys end the pod with a legendary Tier Talk of best iPhone games. Foster was super open with the boys and it is no doubt a must listen. Enjoy.See omnystudio.com/listener for privacy information.

Jonathon Cohen, MD, MS When you hear the word “aggressive,” it can feel overwhelming, but in diffuse large B-cell lymphoma (DLBCL), it can also point to something encouraging – a potential cure. In this episode, we speak with Dr. Jonathon Cohen, of Winship Cancer Institute in Atlanta, GA, about what a DLBCL diagnosis really means, from how this common type of non-Hodgkin lymphoma is identified to current treatment options and emerging therapies. We explain what patients and families need to know about side effects. We also look at new treatments, including CAR T-cell therapy and bispecific antibodies, and the importance of open communication with your care team. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Diffuse large B-cell lymphoma CAR T-cell therapy Stem cell transplantation Bispecific antibodies (immunotherapy fact sheet) Clinical Trial Support Center Additional Blood Cancer United Support Resources: Information Specialists Young Adult Resources Young Adult Online Chat Financial support Free Nutrition Consultations Free telephone/web patient programs SHARE web series Online videos Free booklets Patient Community Support groups Caregiver support Caregiver Workbook Survivorship Workbook Advocacy and Public Policy Mental Health Resources Episode supported by Genmab US, Inc.The post Diffuse Large B-Cell Lymphoma (DLBCL): Breaking Down an Aggressive Lymphoma first appeared on The Bloodline with Blood Cancer United Podcast.

What would you do if you moved out to LA at 18 to chase your dreams, but got handed a non-Hodgkin's lymphoma diagnosis and a 5-year expiration date instead? Our guest Aria fought through chemo, radiation, and 16 separate surgeries, and actually beat it. But the universe wasn't done with her. After just two months of remission, the cancer moved to the temporal lobe of her brain, and doctors gave her one year to live. Spoiler alert: she didn't die. Aria decided to surrender to whatever was going to happen and somehow beat terminal brain cancer. But just when she thought she was in the clear, celebrating her one-year cancer-free anniversary on a road trip to Wyoming, she passed out at the wheel and crashed her car at 80 mph. The impact shattered her occipital bone, essentially detaching her skull from her spine. She woke up completely blind, unable to speak, and unable to walk. Buckle up (literally and figuratively) for a real life Final Destination style episode. Aria is a radiant, unkillable badass, and this conversation is a masterclass in fearless resilience. Follow Sickboy: Instagram: https://www.instagram.com/sickboypodcastTiktok: https://www.tiktok.com/@sickboypodcastDiscord: https://discord.gg/expeUDN

What would you do if you moved out to LA at 18 to chase your dreams, but got handed a non-Hodgkin's lymphoma diagnosis and a 5-year expiration date instead? Our guest Aria fought through chemo, radiation, and 16 separate surgeries, and actually beat it. But the universe wasn't done with her. After just two months of remission, the cancer moved to the temporal lobe of her brain, and doctors gave her one year to live. Spoiler alert: she didn't die. Aria decided to surrender to whatever was going to happen and somehow beat terminal brain cancer. But just when she thought she was in the clear, celebrating her one-year cancer-free anniversary on a road trip to Wyoming, she passed out at the wheel and crashed her car at 80 mph. The impact shattered her occipital bone, essentially detaching her skull from her spine. She woke up completely blind, unable to speak, and unable to walk. Buckle up (literally and figuratively) for a real life Final Destination style episode. Aria is a radiant, unkillable badass, and this conversation is a masterclass in fearless resilience. Follow Sickboy: Instagram: https://www.instagram.com/sickboypodcastTiktok: https://www.tiktok.com/@sickboypodcastDiscord: https://discord.gg/expeUDN

Cutaneous T-cell lymphoma (or CTCL) is a rare form of non-Hodgkin lymphoma that begins in T lymphocytes, a kind of white blood cell that plays a crucial role in the immune system. And Citius Oncology is focused on developing and commercialising a targeted immune therapy for the initial indication of the treatment of persistent or recurrent CTCL. In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Leonard Mazur, CEO and Chairman of Citius Pharmaceuticals about the launch of its first FDA-approved drug, Lymphir, for CTCL. Mazur discusses the landscape of unmet need in this space, as well as Citius' advancement of clinical trials in other areas without approved treatments and the future horizon for such oncological innovations. You can listen to episode 265 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it – and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.

Why does bread in Europe not bother your gut the way it does in the United States — and what does glyphosate have to do with Hashimoto's, hypothyroidism, and other serious health conditions? If wheat and dairy trigger inflammation, fatigue, anxiety, or loose stools at home, why can they feel totally fine abroad? In this episode, I share what happened when I recently spent two weeks in Spain and Portugal and ate gluten after being gluten-free for 14 years. Instead of feeling bloated, irritable, and anxious like I normally would after eating gluten, I actually felt completely fine. That's right — no symptoms whatsoever. You've probably heard of others having similar experiences, but the science and history behind why this happens is fascinating. I explain why European wheat is different from U.S. wheat, and how the U.S. food system's agricultural and dairy practices have created a perfect storm of problems since at least 1996. We'll get into how glyphosate and other herbicides have infiltrated our food system, plus what the research says about gut bacteria disruption, intestinal permeability, and thyroid/endocrine impacts. There's also a very real connection between glyphosate and non-Hodgkin lymphoma that has led to hundreds of thousands of lawsuits. Then we talk dairy: why the EU banned synthetic growth hormones, fatty acid profiles (grass-fed vs. grain-fed), and how mold-contaminated feed can contribute to issues that I often see show up in toxin testing. This may all seem like bad news from the U.S. perspective, but there are still things we can do here to protect our health without missing out on the good things in life. One major benefit of living in the U.S. is that there are unlimited options, and there are many swaps we can make that avoid the toxins and inflammatory ingredients. And maybe, this is even the sign you need to take that much-deserved vacation to test out Europe's food system for yourself! Disclaimer: This information is being provided to you for educational and informational purposes only. It is being provided to educate you about how to take care of your body and as a self-help tool for your own use so that you can reach your own health goals. It is not intended to treat or cure any specific illness and is not to replace the guidance provided by your own medical practitioner. If you are under the care of a healthcare professional or currently use prescription medications, you should discuss any dietary changes or potential dietary supplement use with your doctor, and should not discontinue any prescription medications without first consulting your doctor. This information is to be used at your own risk based on your own judgment. If you suspect you have a medical problem, we urge you to take appropriate action by seeking medical attention.In This Episode: [2:30] The 2 most common food triggers in my clients[6:20] Why grains and wheat hit differently in Europe than they do in the US[7:45] What is GMO and glyphosate?[11:25] How glyphosate affects the body — the link to non-Hodgkin lymphoma[19:25] The night I decided to be a functional health practitioner[21:30] The regulatory environment that keeps food in the EU safer[22:43] Dairy in the EU vs. the US[26:25] The missing cultural piece in the US[29:35] How to support our health despite all the bad newsConnect with Sophie: Instagram: @shetalkshealthWebsite: shetalkshealth.comApply to work with us: www.shetalkshealth.com/callThyroid Breakthrough Call: https://thyroidhealthaudit.shetalkshealth.com/thyroid-health-auditThe Mineral Reset (HTMA): https://shethrives.shetalkshealth.com/htma-packageMineral Mocktail (get your energy back now!: https://shetalkshealth.com/mineral-mocktail-guide/Stop guessing with your thyroid & Get Answers Now: https://ace.shetalkshealth.com/home-front

Date: 6/18/26Name of podcast: Dr. PatientEpisode title and number: 33 Second Opinions in HealthcareEpisode summary: In Episode 33 of Dr.Patient, host and physician Dr. Heather Johnston is joined by two guests — Mia and Joby — to share their personal experiences navigating the medical second opinion process after serious cancer diagnoses. Mia, a breast cancer survivor, and Joby, who faced three separate cancer diagnoses including bone cancer and Hodgkin's lymphoma, open up about the emotional, logistical, and financial hurdles of seeking second opinions — from tracking down pathology slides and paying out-of-pocket fees to encountering dismissive surgeons and conflicting treatment recommendations. Together, they explore why patients seek second opinions (complex diagnosis, distrust, rare illness), what happens when doctors disagree on cancer treatment, and how factors like bedside manner, doctor-patient trust, institutional coordination, and staying current on medical research all influence which physician a patient ultimately chooses. If you've ever wondered whether to get a second medical opinion, how to navigate the healthcare system during a health crisis, or what questions to ask your oncologist, this episode offers honest, real-world insight from both a doctor's and patient's perspective.Guest(s): Joby, MiaPodcast website: www.drpatientpodcast.comPodcast email, become a guest: drpatientpodcast@gmail.com

At 25, Jace Yawnick was building a career in health and wellness sales, chasing growth, status, and the usual young adult fantasy of getting somewhere fast. Then his body stopped cooperating. Fatigue turned into chemotherapy. The diagnosis was primary mediastinal B cell non Hodgkin lymphoma, and the rest of his life split into before and after. Now in remission, he talks about cancer the way people actually live it, not the way nonprofits package it. He gets into survivorship, mental health, young adult isolation, and the deadening absurdity of prior authorization. One of the sharpest parts of the conversation lands on a simple American insult disguised as policy: treatment innovation means very little when insurance can still deny the scan, the drug, or the next step. Jace has seen that firsthand, including during routine monitoring after active treatment. This episode tracks what happens when a young cancer patient becomes a public voice and refuses to play mascot. It covers oncology, insurance, remission, advocacy, and the long mental hangover that follows survival. It also names the part too many institutions dodge: the system works great right up until it doesn't, and when it fails, patients get handed the bill, the panic, and a camera if they want anyone to care. RELATED LINKSJace Beats CancerJace Yawnick on LinkedImConquer Cancer ArticleCURE Today ArticlePyure BrandsFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Redshirt freshman goalkeeper Rylie Kuyper opens up about her recent cancer diagnosis of Hodgkin's lymphoma with LSU soccer SID Alyssa Leal. Kuyper is remaining in great spirits despite the life-changing news and shares more about her positive outlook for the future. Her story has been picked up from PEOPLE.com, the TODAY Show and other national publications.

What do you learn when you face cancer, not once but twice?Savio P. Clemente has done it and came out the other side to share the squiggly lessons we all need. This episode of Embrace the Squiggle, Colleen and Ashleigh speak with keynote and TEDx speaker, board-certified wellness coach, journalist, and two-time cancer survivor Savio P. Clemente about pressure and post-crisis leadership.Savio recounts being diagnosed in 2014 with stage three non-Hodgkin's lymphoma, undergoing six rounds of R-CHOP, and being cancer-free for a decade before a relapse. His experience fighting cancer tought him the importance of integrative healing, compassion, and the power of silence and stillness.

It's been a tough road for one of our own, but the whole community has been right behind him. Now, the Big Marn has some positive news about his battle with non-Hodgkin's lymphoma.See omnystudio.com/listener for privacy information.

Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/05-06-2026Nesta sexta-feira, analisamos atualizações em endocrinologia reprodutiva, uma revolução na terapia celular oncológica e o papel dos jogos sérios no julgamento clínico. Abordamos as diretrizes atualizadas da American Thyroid Association, que estabelecem valores de referência por trimestre para TSH e T4, priorizando o rastreamento direcionado. Detalhamos os dados promissores da nova terapia CAR-T in vivo da Legend Biotech para linfoma não-Hodgkin, que gera as células de defesa diretamente dentro do corpo do paciente. Por fim, discutimos no Radar um estudo do JAMA que comprova como o jogo eletrônico Night Shift reduziu erros médicos e a subestimativa de traumas em idosos na emergência. Afya News. Informação médica confiável e atualizada no seu tempo.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into some of the most significant advancements in scientific research, clinical trials, and regulatory landscapes within the industry. These developments are shaping the future of patient care and drug development significantly. Starting with Legend Biotech's LB2501, which achieved an impressive 100% response rate in a Phase 1 study for non-Hodgkin lymphoma using in vivo CAR T-cell therapy. This breakthrough highlights the transformative potential of CAR T-cell therapies in oncology, especially for B-cell lymphomas. Such success opens the door for accelerated regulatory pathways, offering hope to patients with limited treatment options. In another key development, JJP Biologics shared positive interim data from its Phase 1b trial of nebaprubart targeting CD89 in linear IgA disease. This monoclonal antibody is promising in treating autoimmune conditions by targeting specific disease mechanisms. Meanwhile, GSK's Velzatinib (IDRX-42) achieved a 61% response rate in Phase 1/1b trials for gastrointestinal stromal tumors, showing efficacy against cases resistant to treatments like imatinib. Johnson & Johnson's Nipocalimab met its primary endpoint in a Phase 2 study for systemic lupus erythematosus, underscoring the potential of FcRn blockade in managing autoimmune diseases. Zenas Biopharma's Phase 3 data for Obexelimab targeting CD19/FcγRIIB in IgG4-related disease further emphasizes the role of targeted therapies in managing complex autoimmune disorders. On the regulatory front, Foundation Medicine's FoundationOne Blood Test received FDA approval as a companion diagnostic for Pfizer's Talzenna (talazoparib) to treat prostate cancer with homologous recombination repair gene mutations. This approval underscores the growing importance of precision medicine and companion diagnostics in tailoring cancer treatments based on genetic profiles. Additionally, Lupin and Natco Pharma secured FDA approval for their generic version of Eribulin Mesylate Injection, essential for reducing healthcare costs and improving patient access to vital therapies. Eli Lilly's collaboration with Ascidian Therapeutics focuses on RNA exon editing for kidney diseases, potentially revolutionizing treatment approaches by correcting genetic errors at the RNA level. This partnership reflects a burgeoning interest in RNA-based therapies and their capacity to address unmet medical needs. Regeneron expanded its pact with CytomX Therapeutics to develop conditionally active bispecific antibodies, emphasizing innovation in oncology drug discovery. Such collaborations combine expertise across companies to expedite cutting-edge therapies' development. In terms of funding, NewLimit's successful $435 million Series C round aims to advance epigenetic reprogramming medicine towards human trials. This initiative highlights the burgeoning field of aging biology and its implications for extending healthy human lifespan through innovative therapeutic approaches. Similarly, Immu Biosciences raised $53 million to enhance its immunology platform using AI/ML technologies, underscoring AI and machine learning's critical role in accelerating drug development processes. Turning our gaze towards China's expanding influence on the global biotech stage, Akeso's presentation at ASCO 2026 marked a significant milestone as it became the first-ever Chinese dataset featured in a plenary session. This achievement underscores China's growing prominence in biotechnology and highlights its commitment to advancing innovative medical solutions globally. Simultaneously, Gilead's strategic partnership with Cencora aims to enhance access to CAR-T therapies like Yescarta and Tecartus by expanding their network of treatment centers. CAR-T therapies represent a paradigm shift in cancer treatment by offering personalized options for certain types of cancer. Despite challenges such as Roche's setbacks with its oral SERD drug giredestrant in breast cancer trials, innovation continues unabated. Zevra Therapeutics' launch of Miplyffa for Niemann-Pick disease type C exemplifies efforts to transform rare disease markets by improving patient outcomes through increased access and tailored treatment strategies. Finally, Eli Lilly's acquisition spree reflects broader trends where pharmaceutical companies increasingly integrate Chinese innovations into their development pipelines. This period marks a transformative phase characterized by collaboration between global pharma giants and Chinese biotechs, signaling an era where innovation is globalized and aimed at addressing critical healthcare challenges worldwide. These advancements reflect a dynamic period of innovation within the pharmaceutical and biotech industries. The focus on personalized medicine, targeted therapies, and groundbreaking technologies like RNA editing indicates a shift towards more precise treatment modalities. As these discoveries transition from research phases to clinical applications, they hold the potential to transform patient care significantly. Strategic partnerships and substantial funding initiatives illustrate a robust ecosystem supporting these innovations' rapid advancement. As regulatory bodies continue approving novel therapeutics and diagnostics, the emphasis on personalized healthcare will likely drive future developments, ultimately leading to improved patient outcomes worldwide. As we continue navigating these developments, it's clear that the pharmaceutical and biotech sectors are on the cusp of transformative breakthroughs that promise to redefine healthcare delivery across multiple domains. Thank you for tuning into Pharma Daily; stay informed and stay ahead.Support the show

Dakota Carson was diagnosed with Hodgkin's lymphoma inJanuary, and his response was to prepare for war. In this episode of Alex Perry on Fire, Dakota walks through the long road to his diagnosis, the new immunotherapy and chemotherapy plan that cut his treatment nearly in half, andthe mindset carrying him through it. A candid conversation about facing cancer head on, leaning on family, and finding strength when no one else can see the fight.Your turn to start the fire.Like what you heard today on Alex Perry on Fire? Tell usabout it. Want to share what has helped you on your journey? We want to hear about that, too.Comment on social, DM us or give us a call. Instagram: @alexperryonfire    TikTok: @alexperryonfireCall: 214-506-8023

Swanny opens the show by reflecting on Memorial Day before diving into the ACC Baseball Championship, where Georgia Tech Yellow Jackets baseball capped off a dominant season with a convincing win over North Carolina Tar Heels baseball. He also discusses Clemson football's recent recruiting surge as the Tigers add five commitments in a week, including Carter Blackwell and Carter Jones, while examining the realities of recruiting in the NIL era and why commitments today must be viewed differently than ever before.The show then shifts to more meaningful news as Clemson defensive tackle Hevin Brown-Shuler speaks publicly for the first time about his battle with Hodgkin lymphoma. Swanny shares comments from both Brown-Shuler and Dabo Swinney, highlighting the support surrounding the young Tiger and the positive outlook for his recovery. Later, Swanny pays tribute to former Clemson athletic director Terry Don Phillips following news of his passing. From hiring Dabo Swinney to shaping the future of Clemson athletics through landmark coaching hires and facility improvements, Swanny reflects on Phillips' lasting legacy and the impact his belief and leadership continue to have on Clemson today. The show wraps up with a look at the NCAA Baseball Tournament field, the NBA and NHL playoffs, and what lies ahead for college baseball's postseason.

Swanny opens the show breaking down the wild start to the ACC Baseball Tournament after Duke Blue Devils baseball outslugged NC State Wolfpack baseball 21-12 in a four-hour marathon that pushed back Clemson's matchup with Notre Dame Fighting Irish baseball in Charlotte.Plus, Swanny reacts to the difficult news surrounding Clemson defensive tackle Hevin Brown-Shuler's Hodgkin lymphoma diagnosis and shares thoughts on the support pouring in from the Clemson community. 

A lot happened at the NFL owner's meeting and Ryan's got all of it. Nashville officially gets Super Bowl 64 in 2030. Minnesota gets the 2028 draft — good news for Packer fans within driving distance. International games are expanding to 10 per season starting in 2027, with Goodell eyeing 16 eventually. Ryan's cautiously okay with the expansion until someone says Japan, at which point he's fully on board and also realizes he'll never actually go. The Bears got a special briefing on their stadium situation, because the other 31 owners apparently need a progress report on why Chicago still doesn't know where their team plays. The only two viable options remain Arlington Heights and Hammond, Indiana — meaning the days of Bears fans talking trash about small-town Wisconsin are officially over. Ryan has thoughts. Also: Rashee Rice is in jail after a marijuana violation voided his deferred sentencing. Josh Sweat is unhappy in Arizona, Ganon is in Green Bay, and Ryan does the math on what a third-round pick for a number-three edge rusher might look like. He's making that call. And finally — the Packers briefly discussed bringing Davante Adams back before it went nowhere, and they signed Vanderbilt DB Marlon Jones, who beat stage-three Hodgkin's lymphoma last year and is the feel-good story of the offseason.

A lot happened at the NFL owner's meeting and Ryan's got all of it. Nashville officially gets Super Bowl 64 in 2030. Minnesota gets the 2028 draft — good news for Packer fans within driving distance. International games are expanding to 10 per season starting in 2027, with Goodell eyeing 16 eventually. Ryan's cautiously okay with the expansion until someone says Japan, at which point he's fully on board and also realizes he'll never actually go. The Bears got a special briefing on their stadium situation, because the other 31 owners apparently need a progress report on why Chicago still doesn't know where their team plays. The only two viable options remain Arlington Heights and Hammond, Indiana — meaning the days of Bears fans talking trash about small-town Wisconsin are officially over. Ryan has thoughts. Also: Rashee Rice is in jail after a marijuana violation voided his deferred sentencing. Josh Sweat is unhappy in Arizona, Ganon is in Green Bay, and Ryan does the math on what a third-round pick for a number-three edge rusher might look like. He's making that call. And finally — the Packers briefly discussed bringing Davante Adams back before it went nowhere, and they signed Vanderbilt DB Marlon Jones, who beat stage-three Hodgkin's lymphoma last year and is the feel-good story of the offseason.

Ep. 205 - Join Kimberly for part 2 of her deep-dive with the incredibly talented and incredibly inspiring Charles Porter. Last week, we got to know Charles as a Duke football player turned Hollywood entrepreneur. Today, we go deeper into the mindset that makes Charles a survivor, a leader, and a beacon of hope. We discuss his career as an actor, a producer, and his battles with stage 4 Hodgkin's lymphoma. Discover how Charles uses the power of brainwashing, creates strict boundaries, and goes all-in on life to navigate his cancer journey.  Chapter Timestamps: 1:15 - Duke Football & The NFL: Transitioning from football to a new career path. 6:42 - Hollywood Bound: Charles' early years in LA, including his first job in marketing and landing a role on ESPN's "Beg, Borrow, or Deal". 10:11 - Producing & The Hollywood Grind: Shifting gears to producing and finding proactive ways to grow in his career. 13:17 - Stage 4 Cancer Diagnosis: Charles shares the poignant story of his cancer diagnosis, the physical symptoms he missed, and the emotional impact on his life and relationships. 21:55 - The Cancer Journey & Treatment: Charles discusses his experience with three bone marrow transplants, various treatments, and the emotional battle he and his family faced. 27:14 - The Power of the Mindset: Discover Charles' concept of "brainwashing for greatness" and how he used positive affirmations and visualization to stay strong during his treatments. 31:47 - Creating Strong Boundaries: The importance of choosing your circle wisely and ruthlessly protecting your peace. 38:39 - Dealing with Negative Perceptions: Charles' perspective on dealing with mischaracterization and character assassination. 41:40 - The Path to Wisdom & Peace: A discussion on ego, accountability, and his quest for a life of meaning and authenticity. Follow Charles on Instagram: https://www.instagram.com/cfpgram/ And Black Bench Productions: https://www.instagram.com/blackbenchproductions/ Follow Kimberly on Instagram: https://www.instagram.com/kimberlylovi/ Subscribe on YouTube Here: ‪https://www.youtube.com/@iconicnationmedia      

Send us Fan Mail What happens when the version of yourself the world handed you was the version you were taught to fear? This episode is for anyone who has ever quietly wondered if they were allowed to be loved as they are. Sayan sits down with Dr. Joshua Caraballo, industrial-organizational psychologist and author of I'm Not Dead...Yet. Joshua walks through the conviction he made inside a prison cell, the years of believing God wanted to destroy him for being gay, surviving Hodgkin's lymphoma twice, and the slow, deliberate work of falling back in love with himself. They unpack the PERMA model from positive psychology, why questioning what you've been taught is a fruitful exercise even when you keep believing it, and what self-acceptance actually looks like in practice. Honest, unhurried, and quietly hopeful. About the Guest: Dr. Joshua J. Caraballo, PsyD, is an industrial-organizational psychologist, author, performer, and the founder of Dr. Josh Business Solutions. Based in Denver, Colorado, his career centers on inspirational storytelling and applied science for human betterment, particularly for historically marginalized communities. He is the author of the memoir I'm Not Dead...Yet: How I Turned My Misfortunes Into Strengths, which traces his journey through a strict Jehovah's Witness upbringing, mental health struggles, addiction, prison, surviving Hodgkin's lymphoma, and coming home to himself as a gay Puerto Rican man. Key Takeaways: Survival can become a habit. At some point you have to ask whether the life you've been getting through is the life you actually want. Questioning what you were taught is not betrayal, it's a fruitful exercise. Sometimes it brings you back to the same belief. Sometimes it sets you free. Either way, the asking matters. Values aren't preferences. A real value can never harm yourself, others, or the world. If a "value" requires harm to hold, it isn't one. Identity is not always a choice. Some parts of who you are are as fixed as ethnicity. The work isn't changing them, it's recognizing them. The PERMA model: Positive emotion, Engagement, Relationships, Meaning, Achievement and vitality. All five together build a life worth flourishing in. Real change is incremental, not sweeping. Self-love is built in small, repeated acts, not in a single breakthrough moment. Connect With the Guest: Website: https://www.drjosh.solutions/  Book I'm Not Dead...Yet (Barnes & Noble): https://www.barnesandnoble.com/w/im-not-deadyet-dr-joshua-j-caraballo/1145420055 LinkedIn: https://www.linkedin.com/in/dr-josh/  Instagram: https://www.instagram.com/dr_josh_solutions/  Episode Chapters: [00:00] Cold Open: When Survival Becomes a Habit [03:00] The Conviction Joshua Made Inside a Prison Cell (approx.) [06:30] Growing Up Jehovah's Witness, Gay, and Believing God Wanted to Destroy Him (approx.) [10:00] The Power of Questioning What You've Been Taught (approx.) [14:00] How a Real Value Is Different From a Borrowed Belief (approx.) [17:30] Identity, Sexuality, and the Things That Cannot Be Changed (approx.) [20:30] PERMA: The Five Pillars of Human Flourishing (approx.) [24:00] Why Self-Love Is Built in Small, Repeated Steps (approx.) [26:30] Final Reflection: Living for More Than Yourself (approx.)   Want to be a guest on Healthy Mind, Healthy Life? DM on PM - Send me a message on PodMatch DM Me Here: https://www.podmatch.com/hostdetailpreview/avik Disclaimer: This episode is produced for educational and informational purposes only. All views expressed by the guest are their personal opinions alone and do not represent the views of the host or Healthy Mind by Avik™. The Network does not verify, endorse, or assume responsibility for any guest statements. Nothing in this episode constitutes medical, legal, financial, or professional advice, please consult a qualified professional before making any decisions. Listeners are encouraged to engage critically and independently with all content do not consume blindly. Use this content as a starting point for your own reflection and research, not as a substitute for professional guidance. Third-party content is referenced under fair use for informational purposes only. Guest speakers are solely responsible for their own statements. If you have concerns about any content, please contact us here. By listening, you acknowledge and accept this disclaimer in full. Read detailed disclaimer here. Healthy Mind By Avik™ is a global platform redefining mental health as a necessity, not a luxury. Born during the pandemic, it's become a sanctuary for healing, growth, and mindful living. Hosted by Avik Chakraborty, storyteller, survivor, and wellness advocate. With over 6500+ episodes and 200K+ global listeners, we unite voices, break stigma, and build a world where every story matters. Subscribe and be part of this healing journey. Brand: Healthy Mind By Avik™ | Email: https://www.podhub.club/contact | Website: https://www.podhub.club | Based in: India & USA Support the show Want to Be a Guest on Healthy Mind, Healthy Life?

One heavy squat at 400 pounds was all Kalil Sherrod needed to know the poison hadn't won. Seven weeks before this recording, Kalil walked into elitefts HQ to hit his first major milestone since a brutal cancer diagnosis. That moment bridged the gap between his life as an elite performance coach and his reality as a survivor. Through two stem cell transplants and multiple rounds of high-intensity chemotherapy, he developed a conjugate-based survival blueprint—one that reinforces a hard truth: muscle mass is one of the most powerful insurance policies for the human body. Inside the Episode: The 93% Rule: Why maintaining a high performance floor matters more than chasing a peak during a competitive season Conjugate for the Court: Applying Westside methodology to basketball players without sacrificing vertical jump or shooting touch Training Through the Storm: How Kalil adjusted his training split during "ICE" chemotherapy to preserve lean tissue The Youth Development Gap: Why the loss of PE and martial arts is producing more fragile athletes—and how to reverse it The IV Protocol: A critical hydration strategy often overlooked during medical treatment Meet the Guest: Kalil Sherrod is a high-performance coach, author, and founder of Revenants Coaching. A former Division II basketball player, he serves as a Sports Performance Coach for the Thailand Titans and works with athletes at The Spot Athletics. He is the author of The Basketball Player's Training Guide and co-author of the elitefts eBook Mastering Conjugate Programming for Athletes. After surviving Hodgkin's Lymphoma, Kalil has dedicated his work to helping athletes and survivors use strength as a foundation for resilience. Connect with Kalil Sherrod: Instagram: https://www.instagram.com/kalil_sherrod YouTube: https://www.youtube.com/@kalilsherrod4882 Linktree: https://linktr.ee/kalilsherrod The Get Clean Podcast: https://podcasters.spotify.com/pod/show/kalil-sherrod7 The Spot Athletics: https://www.thespotathletics.com Revenants Coaching: https://linktr.ee/kalilsherro Become an elitefts Channel Member: Get early access to Dave Tate's Table Talk and more: @eliteftsofficial Support Dave Tate's Table Talk: FULL Crew Access: https://www.elitefts.com/join-the-crew Limited Edition Apparel: https://www.elitefts.com/shop/apparel/limited-edition.html Programs & More: https://www.elitefts.com/shop/dave-tate-s-table-talk-crew.html TYAO Application: https://www.elitefts.com/dave-tate-s-tyao-application Best-Selling elitefts Products: Pro Resistance Bands: https://www.elitefts.com/shop/bands.html Specialty Barbells: https://www.elitefts.com/shop/bars-weights/specialty-bars.html Wraps, Straps, Sleeves: https://www.elitefts.com/shop/power-gear.html Sponsors: Get an extra 10% OFF at elitefts (CODE: TABLE TALK): https://www.elitefts.com/ Get 10% OFF Marek Health Labs (CODE: TABLETALK): https://marekhealth.com/tabletalk Free 8-count LMNT Sample Pack: http://www.drinklmnt.com/tabletalk Support Massenomics: https://www.massenomics.com/ Save 20% on MASS Research Review (CODE: ELITEFTS20): https://massresearchreview.com/ Get 10% OFF RP Hypertrophy App (CODE: TABLE TALK): https://rpstrength.com/pages/hypertrophy-app

One heavy squat at 400 lbs was the only signal Kalil Sherrod needed to know the poison hadn't won yet. Seven weeks before recording this episode, Kalil walked into elitefts HQ to hit his first heavy milestone since a grueling cancer diagnosis—a moment that bridged the gap between his life as an elite performance coach and his reality as a survivor. Through two stem cell transplants and rounds of high-intensity chemo, he has refined a conjugate-based survival blueprint that proves muscle mass is the ultimate insurance policy for the human immune system. INSIDE THE EPISODE: The 93% Rule: Why maintaining a high performance floor is more critical than chasing a ceiling during a competitive season. Conjugate for the Court: How to apply Westside methodology to basketball players without sacrificing their vertical or shooting touch. Training Through the Storm: The specific adjustments Kalil made to his training split while undergoing "ICE" chemotherapy to preserve lean tissue. The Youth Developmental Gap: Why the loss of traditional PE and martial arts is creating a generation of fragile athletes and how to fix it. The IV Protocol: A critical, overlooked hydration tip for anyone navigating medical treatments that often gets ignored by hospital staff. MEET THE GUEST: Kalil Sherrod is a high-performance coach, author, and the founder of Revenants Coaching. A former DII basketball player, he currently serves as the Sports Performance Coach for the Thailand Titans professional basketball organization and coaches at The Spot Athletics. Kalil is the author of The Basketball Player's Training Guide and co-author of the elitefts eBook Mastering Conjugate Programming for Athletes. After surviving Hodgkin's Lymphoma, he has dedicated his work to helping athletes and fellow survivors use strength as a tool for radical resilience. CONNECT WITH KALIL SHERROD: Instagram: https://www.instagram.com/kalil_sherrod YouTube: https://www.youtube.com/@kalilsherrod4882 Linktree: https://linktr.ee/kalilsherrod The Get Clean Podcast: https://spotify.com/0 The Spot Athletics: https://www.thespotathletics.com Revenants Coaching: https://linktr.ee/kalilsherro SUPPORT DAVE TATE'S TABLE TALK: FULL Crew Access: https://www.elitefts.com/join-the-crew Limited Edition Apparel: https://www.elitefts.com/shop/apparel/limited-edition.html Programs & More: https://www.elitefts.com/shop/dave-tate-s-table-talk-crew.html TYAO Application: https://www.elitefts.com/dave-tate-s-tyao-application ELITEFTS GEAR: Pro Resistance Training Bands: https://www.elitefts.com/shop/bands.html Specialty Barbells: https://www.elitefts.com/shop/bars-weights/specialty-bars.html Wraps, Straps, Sleeves: https://www.elitefts.com/shop/power-gear.html SPONSORS: elitefts: (CODE: TABLE TALK) https://www.elitefts.com/ Marek Health Labs: (CODE: TABLETALK) https://marekhealth.com/tabletalk LMNT: (Free Sample Pack) http://www.drinklmnt.com/tabletalk Massenomics: https://www.massenomics.com/ MASS Research Review: (CODE: ELITEFTS20) https://massresearchreview.com/ RP Hypertrophy App: (CODE: TABLE TALK) https://rpstrength.com/pages/hypertrophy-app

This episode is really special to me.You're going to meet two girls who are both showing us what strength looks like… just in very different ways.First, you'll meet Leahla. Right now, she's going through treatment for Hodgkin's lymphoma. And the way she talks about it? The way she carries herself? It stopped me in my tracks.She's not looking for pity. She's not calling herself a “nebach.” Her words: “We're not nebachs. We're heroes.”And once you hear her explain what that means… you won't forget it.Then you'll meet Sari.After her baby sister spent time in the NICU, Sari realized something powerful: She doesn't just want to learn… she wants to help.She's already thinking about becoming a nurse one day, maybe in oncology, maybe in the NICU… and the way she talks about caring for people, really seeing them, is something every kid (and adult!) needs to hear.So this episode is about two kinds of strength: ✨ The strength to go through something hard ✨ And the strength to step up and help others through it 

Dawn Richard is a proud New Orleans native and a true Renaissance Woman: singer; animator and Adult Swim creative consultant and owner of Papa Ted's vegan food truck in New Orleans.  Dawn went vegan back in 2013, in solidarity with her dad after he received a non-Hodgkin lymphoma diagnosis. She talks about getting naked for PETA, the ethical intentionality behind her food truck and what (not-vegan) food she misses the most but will never eat again.  Then we crack into the history & explore the culture of what is, perhaps, New Orleans' oldest food tradition: crawfish! Food historian Dr Zella Palmer introduces host Rachel Belle to Al Scramuzza, the city's late Crawfish King, and shares her favorite places to experience a crawfish boil in the city.    Become a Cascade PBS member and support public media!     Watch Rachel's Cascade PBS TV show The Nosh with Rachel Belle.   Sign up for Rachel's (free!) biweekly Cascade PBS newsletter for more food musings.   Follow along on Instagram.   Order Rachel's cookbook Open Sesame. 

Gwyneth sits down with Dr. Dawn Mussallem, the chief medical officer for Fountain Life, a longevity clinic powered by AI. They talk about Dawn's incredible health journey–from beating stage four non-Hodgkin lymphoma while in medical school to undergoing a heart transplant at 46–and how that experience now informs her work in the medical field and integrating the powers of AI into health care. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices